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Abstract 
Giardia intestinalis is the most common human protozoan pathogen, infecting over one 
billion people worldwide. It is responsible for a pathology named giardiasis, from which 
pathogenicity mechanisms and the major host defenses against the infection are not well 
characterized. While infecting, this protozoon undergoes antigenic variation, a remarkable but 
poorly understood mechanism that allows the parasite to evade the host’s immune defense 
activity, where only one Surface-specific Variant Protein (VSP) is expressed at a particular time. 
VSPs are epigenetically regulated and share some structural characteristics, namely CXXC motifs, 
with a novel Giardia protein family, the High Cysteine Proteins (HCPs). Several members from the 
HCP family showed up-regulation during parasite-host interactions, including 91707. Trophozoites 
transfected with this protein carrying an HA-tag showed change in cellular localization through 
different passages, particularly nucleus and, later on, plasma membrane. 
Due to the similarities between VSP and HCP protein families there were three main 
objectives in this project. The first one was to confirm that localization changes in these HCPs 
were really occurring in vitro. If so, and to avoid extra factors associated to episomal protein 
expression, the second objective was focused on the expression and purification of recombinant 
HCPs for the production of specific antibodies to evaluate the cellular localization of 91707. 
Finally, verify the presence of one or more regulatory elements of transcription by miRNAs in 
some HCPs sequences to evaluate if this protein group could be regulated in the same way as 
VSPs are. 
Regarding localization of 91707-HA in distinct transfectants, the results showed that 
there is, indeed, change in protein cellular localization, which may indicate that the trophozoites 
adapted to the overexpression of 91707-HA. The production and purification of 91707 was 
optimized; however, the final confirmation of the presence of this protein did not give the 
expected result, whereby the protein sample was sent to mass spectrometry analysis. Finally, 
qPCR results may indicate the presence of some miRNAs that could target HCPs sequences during 
parasite-host interactions. Nevertheless, further assays are needed in to verify the mechanism 
behind HCP regulation.   
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Resumo 
 Giardia intestinalis é o protozoário patogénico mais comum em humanos e infecta mais 
de um bilião de pessoas mundialmente. É responsável pela patologia denominada giardíase, cujos 
mecanismos de patogenicidade e as principais defesas do hospedeiro contra a infeção ainda não 
estão totalmente caraterizados. Enquanto infecta, este protozoário sofre variação antigénica, um 
mecanismo notável mas pouco estudado que permite ao parasita evadir as defesas do 
hospedeiro, havendo apenas a expressão de uma única Variant-specific Surface Protein (VSP) de 
cada vez. As VSPs são reguladas epigeneticamente e possuem algumas caraterísticas estruturais 
comuns, nomeadamente motivos CXXC, com uma outra família de proteínas de Giardia, as High 
Cysteine Proteins (HCPs). Vários membros desta família estão sobre-expressos durante interações 
parasite-hospedeiro, incluindo a proteína 91707. Trofozoítos transfectados com esta proteína e o 
tag de fusão HA mostraram diferenças na localização ao longo das passagens, nomeadamente no 
núcleo e, mais tarde, na membrana plasmática. 
 Devido às semelhanças entre as famílias de proteínas VSPs e HCPs, existiram 3 
objetivos principais neste projeto. O primeiro foi a confirmação da alteração na localização celular 
de 91707-HA in vitro. Caso se confirmassem, e para evitar factores adicionais associados à 
expressão epissomal da proteína, o segundo objetivo foi focado na expressão e purificação de 
HCP recombinantes para a produção de anticorpos específico de modo a avaliar a localização 
celular de 91707. Por fim, verificar a presença de um ou mais elementos de regulação da 
transcrição por miRNA em algumas sequências de HCPs para avaliar se esta família de proteínas 
poderia ser regulada de um modo semelhante às VSPs.  
Relativamente à localização de 91707-HA em diferentes transfectantes, os resultados 
mostraram que há, de facto, alteração na localização celular da proteína, o que pode indicar que 
os transfectantes se adaptaram à sobre-expressão de 91707-HA. A produção e purificação de 
91707 foi otimizada; no entanto, a confirmação final da presença da proteína não mostrou o 
resultado esperado, pelo que uma amostra da mesma foi enviada para análise por espetrometria 
de massa. Por fim, os resultados de qPCR poderão indicar a presença de alguns miRNAs que 
tenham como alvo sequências de HCPs durante interações parasita-hospedeiro. Ainda assim, 
novos testes são necessários para verificar os mecanismos por detrás da regulação de HCPs.  
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1. Introduction 
1.1 Cell Biology of Giardia 
Giardia intestinalis, also known as Giardia lamblia or Giardia duodenalis, is an eukaryotic 
intestinal parasite that belongs to the family Hexamitidae (order Diplomonadida) and the genus 
Giardia, being worldwide distributed (Cavalier-Smith T., 2003). This parasite is considered to be 
the most common intestinal pathogenic protozoa of humans. G.intestinalis is responsible for the 
disease named giardiasis, also known as "Beaver Fever" (Amar et al., 2002). It can also infect 
various animal species such beavers, cows and domestic dogs and cats. There are eight 
assemblages (A to H) that have different genetic backgrounds and host specificity, but are 
morphologically identical. Humans and other animals like dogs and cats are infected by 
assemblages A and B, the two major genotypes of the protozoa. These two assemblages diverge 
in approximately 20% at the DNA level and although the available data in this matter is limited, 
some studies suggest that the infection cause by assemblage A leads to more severe symptoms 
of the pathology, but B isolates may be more common worldwide (Singh et al., 2009). The other 
Giardia assemblages include: assemblage C and D infecting dogs, E which infects hoofed animals, 
F, G and H having as hosts cats, rodents and seals, respectively. Assemblage E, isolate P15, is the 
only non-AB isolate that can be efficiently grown in vitro (Ankarklev et al., 2010). 
Giardia intestinalis’ isolates are characterized by the presence 
of four pair of flagella, two nuclei, lack of aerobic mitochondria and a 
different genetic code (Tovar, J., 2003). Giardia also lacks peroxisomes 
and Golgi apparatus and owns lysosome-like peripheral vesicles, known 
as PV’s (Carranza & Lujan, 2010). This protozoon is an interesting model 
for cell biology, since it has undergone a reductive evolution (early-
divergent) and presents evidence for lateral gene transfer.   
Giardia is a parasite with low infection doses, whereby the 
ingestion of only ten cysts can cause infection. The disease can be 
diagnosed by finding cysts or trophozoites, showed in Figure 1, the two 
main forms of the parasite, in the feces. Both of these life cycle stages 
have a very distinct appearance (Roxström-Lindquist et al., 2005). 
Figure 1. Giardia lamblia 
stages. (A) Giardia 
trophozoite. (B) Giardia cyst 
[From: Touz MC, J., 2011]. 
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Figure 2. Life cycle of Giardia intestinalis [From: 
Ankarklev, J., 2010]. 
1.2  Life Cycle of Giardia and Transmission of Giardiasis 
Giardia’s life cycle is quite simple and it is shown in Figure 2. The cycle begins when 
contaminated food or water or fomites with infective cysts are ingested by host, human or 
animals. The cyst is a non-motile and highly resistant form that allows the parasite to survive 
under severe and hostile conditions (Palm et al., 2003). After ingestion, occurs in the small 
intestine a process named excystation. In this process, the cysts undergo a change of 
environmental conditions, such as pH by the gastric acid in the host stomach, leading to the 
metabolic activation of the cysts – the opening of the rigid and protective cyst wall and its 
degradation by cysteine proteases (Ankarklev et al., 2010). The process of excystation lasts about 
ten minutes and each cyst releases two trophozoites, which will colonize the mucosa of the small 
intestine (Adam, RD, 2001). 
In the intestine the trophozoites 
multiply by binary fission remaining free or 
attaching to the host epithelial cells through 
the ventral disc, a very complex structure 
composed by several vesicles and 
microtubules, which allows the parasite to be 
protected from the peristaltic flow. 
Trophozoites are motile due to their four pairs 
of flagellae and are about 12-15 µm long and 
5-9 µm wide (Ankarklev et al., 2010).  
As the parasites transit towards the 
colon, another process occurs: encystation. This process is induced by factors inherent to the 
host, such as high levels of biliary secretions and basic pH, which lead to the transformation of 
the motile trophozoite into the infective cyst (Lauwaet et al., 2007). Encystation involves the 
intracellular synthesis and transport of cyst wall components, as cyst wall protein (CWPs), and 
the assembly of cyst wall filaments. This process comprises two phases: early and late. During 
the early phase, cyst wall components are synthesized and transported by Golgi-like stack of 
membranes to encystation-specific vesicles (ESVs) (Adam, RD, 2001). In turn, ESVs transport 
those components to the nascent cyst wall. There are two important cyst wall proteins, CWP1 
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and CWP2, which are obviously highly expressed along this phase. These proteins are 
transported to the cyst wall by ESVs. In the late phase, the cyst wall filaments start to assembly 
and the trophozoite plasmalemma starts to appear on that region. During this stage, the flagella 
are internalized and the adhesive disc starts to fragment, which blocks the adhesion of the 
parasite to the host cells (Ringqvist et al., 2008).  When the process of encystation is over, the 
motility disappears and the cysts become rounded and filamentous. Each cyst contains one 
trophozoite with four nuclei that starts dividing as the cyst components disassemble. Two 
trophozoites will be separated when they finish cytokinesis and released from the cyst. 
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1.3  Giardiasis: Disease Fundamentals and Current Studies 
Giardiasis is the disease caused by the parasite Giardia intestinalis. Giardia infects nearly 
2% of adults and 6% to 8% of children in developed countries worldwide In the United States of 
America, Giardia infection is the most common intestinal parasitic disease affecting humans. In 
developing countries, nearly 33% of people have had giardiasis (Centers for Disease Control and 
Prevention, 2012).  
The severity and aggressiveness of the pathology is also related with the assemblage 
infecting a particular host. The symptomatic spectrum of the disease is determined by genetic 
and environment factors of the host. Giardia is not an invasive parasite, it does not penetrate the 
epithelium and does not enter to the blood stream, however it penetrates into the intestinal 
crypts (Carranza & Lujan, 2010) causing the partial destruction of the epithelial barrier. Parasite 
attachment to the epithelial cell layer of the small intestine is a critical step in initiating and 
maintaining the infection. After excystation, trophozoites divide by binary fission and give rise to 
several populations. These populations differ in their surface proteins or antigens, expressing 
each parasite a different antigen at a time, which then switches to a different surface protein in 
order to avoid host immune responses (Carranza & Lujan, 2010). This phenomenon is called 
antigenic variation and the surface antigens are variant surface proteins or VSPs.  
Variant-specific surface proteins, VSPs, are a group of cysteine-rich proteins that 
represent around 200 genes of Giardia assemblages A and B (Ankarklev et al., 2010).Their 
molecular weight varies from 20 to 200kDa. These proteins contain both a variable and a semi-
conserved domain, where numerous CXXC amino acid motifs are present. Besides this, they have 
a transmembrane domain, since they are present on the surface (including the flagella and the 
ventral disk), and a unique and highly conserved CRGKA in the carboxy-terminal motif, where ADI 
(arginine deiminase) specifically binds and citrullinates the region. VSPs citrullination is a 
mechanism that apparently is involved in VSP-switching (Touz et al., 2008).  
Antigenic variation phenomenon occurs in Giardia intestinalis trophozoites in vitro every 
6.5 to 13 generations in the two major human-infecting assemblages, although this is dependent 
on the isolate, the growth conditions and the specific VSPs being expressed (Ankarklev et al., 
2010). Only one member of the VSP-family is expressed at a time, except during cellular 
differentiation and VSP-switching.  
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In terms of the pathology, human giardiasis causes defects in the villous structure, due 
to the increase of crypt depth, with different stages of severity. The intestine permeability is also 
affected. In chronic human giardiasis, there is a loss of epithelial barrier function which leads to 
the reduction of the absorptive surface area, consequently causing maldigestion and 
malabsorption of nutrients, sodium, and water (Troeger et al., 2007). Early and recent studies 
have proposed different disease mechanisms in giardiasis, including apoptosis of enterocytes, 
loss of epithelial-barrier function, hypersecretion of chlorides (Cl-), microvillus shortening, 
interference with bile and salt metabolism, among others (Ankarklev et al., 2010). 
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Figure 3. Localization of identified proteins in G. lamblia trophozoites by 
polyclonal mouse antibodies (green) raised against purified recombinant ADI (A), 
OCT (B) and enolase (C). Scale bar: 10 µm   [Adapted from: Ringqvist et al., 2008]. 
1.4  Parasite-Host Interactions 
Giardia is a parasite that nowadays can easily be grown in vitro in optimal culture 
conditions, which allows the accomplishment of a variety of studies. Transcriptomic studies of 
Giardia intestinalis during parasite-host interactions are highly relevant since they can disclose 
the mechanism behind the infection. An in vitro model has been established where Giardia cells 
are seeded over a Caco-2 cell monolayer and allowed to interact for various periods of time 
after which both cell types are collected and its RNA extracted for microarray studies (Roxström-
Lindquist et al., 2005; Ringqvist et al., 2011).  
Caco-2 cells, a cell line isolated from colon sarcomas, have been the current accepted in 
vitro model for intestine epithelial cells, since cell-cell contact triggers differentiation into 
enterocyte (Roxström-Lindquist et al., 2005; Sambuy et al., 2005). There is a group of specific 
proteins that are exceptionally released during parasite-host interactions, namely acute 
giardiasis. Among them, there are arginine deiminase (ADI) and ornithine carbamoyl transferase 
(OCT) (Ringqvist et al., 2011). These proteins are related to arginine metabolism. Giardia 
captures arginine by an arginine-ornithine antiporter, releasing ornithine to the surrounding 
area (Stadelmann et al., 2012). Intestinal epithelial cells’ arginine uptake is inhibited by the 
release ornithine, but this does not affect Giardia. Thus, with this mechanism, the parasite has 
the ability to starve host cells by an arginine-dependent pathway, reducing cell-host 
proliferation.  
Enolase enzyme is also released during parasite-host interactions and it is involved in 
Giardia excystation. It was shown to be present on the wall of mature cysts and cell membrane, 
flagella and cytosol of trophozoites, but not in ESVs (Castillo-Romero et al., 2012).  
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Using recombinant biology technology, protein analysis techniques and 
immunofluorescence microscopy it was possible to determine the localization of ADI, OCT and 
Enolase metabolic proteins. ADI and Enolase are mainly expressed in the cytoplasm, showing a 
punctuated pattern in that area, while OCT localizes in cytoplasm but with a strong 
accumulation near the plasma membrane seen on Figure 3 (Adapted from Ringqvist et al., 
2008). 
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1.5  The Variant Surface Protein family of Giardia intestinalis  
The Variant Surface Proteins (VSPs) involved in the antigenic variation mentioned 
previously, are a group of cysteine-rich proteins represented by more than 200 genes in Giardia 
assemblages A and B (Ankarklev et al., 2010).Their molecular weight varies from 20 to 200kDa. 
These proteins contain both a variable (N-terminal) and a semi-conserved (C-terminal) domain, 
where numerous CXXC amino acid motifs are present and therefore their aminoacid sequence is 
very cysteine rich. These motifs are represented by orange boxes in 
Figure 4 (Adapted from: Ankarklev et al., 2010). VSPs have a 
transmembrane domain of type-I integral membrane proteins and a 
unique and highly conserved CRGKA carboxy-terminal motif, where ADI 
(arginine deiminase) specifically binds and citrullinates the R residue. 
VSPs citrullination is a mechanism that apparently is involved in VSP-
switching (Touz et al., 2008).  
In vivo the switching is triggered by the pressure induced by the 
adaptative immune system from the host, preventing the clearance of the 
infection. The name antigenic variation derives from the fact that 
homologous cell surface molecules that are antigenically different 
undergo a continuous switching (Prucca et al., 2011). VSP switching 
occurs in vitro spontaneously every 6.5 to 13 generations in the two major human-infecting 
assemblages, although this is dependent on the isolate, the growth conditions and the specific 
VSPs being expressed. Only one member of the VSP-family is expressed at a time, except during 
cellular differentiation and VSP-switching (Ankarklev et al., 2010).  
  
Figure 4. Variant-specific 
Surface Protein structure 
[Adapted from: 
Ankarklev et al., 2010]. 
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1.6  High Cysteine Proteins in Giardia intestinalis 
 
High Cysteine Proteins, HCPs, are a family of proteins rich in cysteine content as its name 
refers to. In Giardia intestinalis there are 86 members of this family with only 62 of them having 
a transmembrane domain in their amino acid sequence – type I integral proteins (Davids et al., 
2006). 
There is still very few knowledge regarding this 
protein family, whereby so far only the study from Davids 
et al., 2006 contributes to its characterization. 
HCPs have 11-16% cysteine content within several 
CXXC and CXC motifs with a molecular weight range from 
50 to 250kDa. Figure 5 shows the localization of a High 
Cysteine Non-variant Cyst protein, HCNCp (Adapted from 
Davids et al., 2006). This protein seems to be localized in 
the nucleus or its periphery in the trophozoite stage, but in 
the cyst form the HCNCp is found in the cell body of the 
cyst. This suggests that this particular protein may be 
important in the trophozoite stage, since it is accumulated 
in the cyst during late encystation. A set of HCPs also 
showed upregulation in microarray data in the presence of 
the histone deacetylases (HDAC) inhibitor FR235222, 
indicating that some members from this protein family maybe regulated at the chromatin level 
(Sonda et al., 2010).  
High Cysteine Proteins present a common amino acid motif to the VSPs, CXXC, which is 
likely to be related with protein folding and response to O2 levels. All the resemblances between 
these two peculiar protein families suggest that HCPs could be a subgroup of VSPs. Additionally, 
it is suggested that HCPs can be regulated the same way VSPs are, by a microRNA mechanism or 
at the chromatin level (Sonda et al., 2010).  
  
Figure 5.  Traffic of HCNCp and Cyst 
proteins during growth and 
differentiation of G. intestinalis 
[Adapted from: Davids et al., 2006]. 
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1.7  miRNA Gene Regulation in Giardia intestinalis  
The control of gene expression is a biological process essential to all organisms. Gene 
expression can be controlled during transcription or post-transcriptionally by mechanisms such 
as RNA transport, mRNA stability, regulation of chromatin structure and post-transcriptional 
modiﬁcations among others (Yilmaz & Grotewold, 2010).  
MicroRNAs (miRNAs) are an abundant class of small non-coding RNAs which post-
transcriptionally regulate the expression of genes based on partial sequence complementarity. 
Usually this regulation results in repression of gene expression and can either occur by mRNA 
degradation or repression of translation (Cai et al., 2009). Several studies in different biological 
fields have shown that this class of RNAs is involved in gene regulation in distinct biological 
pathways (Bartel, 2009). In 1993, Rosalind Lee identified the first miRNA, lin-4, which down 
regulates the levels of LIN-14 protein, being in turn involved in timed regulation of the larval 
development stage in Caenorhabditis elegans life cycle (Lee et al., 1993).   miRNAs are usually 
21-25 nucleotides in length and are present in several organisms, as worms, flies, plants and 
mammals (He & Hannon, 2004). The process of miRNA formation in animals is not completely 
clear, but the general mechanism of its 
biogenesis is known. miRNA transcripts, 
also known as pri-miRNA, are processed 
into pre-miRNA by the RNase-III enzyme 
Drosha, which are precursors with 
approximately 70 nucleotides, in the 
nucleus. These precursors are exported to 
the cytoplasm by the nuclear export 
receptor Exportin-5 through nuclear pore 
complexes. Once in the cytoplasm, another 
RNase-III enzyme, Dicer, cleaves pre-miRNA 
into 20-25 nucleotide miRNA fragments, 
termed mature miRNAs, removing the loop 
region from the sequences as exemplified 
in Figure 6. As mentioned, both Drosha and 
Dicer are RNase-III enzymes with endonuclease activity, meaning cleavage of phosphodiester 
Figure 6. miRNA- and siRNA-mechnisms [Adapted from: He 
and Hannon, 2004].  
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bonds within a polynucleotide sequence. These dsRNA-specific enzymes create 2-nucleotide-
long 3’ overhangs similar to a mini-helix during pri- and pre-miRNA splicing (Kim Narry, 2004). 
The presence of this structure in pre-mRNA makes it suitable to be recognized by Exportin-5. In 
order to turn into functional molecules, double-stranded miRNA sequences suddenly convert 
into single strands and joins the Argonaute protein, forming the RNA-induced silencing complex 
(RISC), to allow target recognition (He & Hannon, 2004). The remaining strain (miRNA*) is 
degraded. The strain which comprises RISC usually has the less stable base-pared 5’end in the 
miRNA/miRNA* duplex (Khvorova et al., 2003). The Argonaute proteins are included in an 
evolutionary conserved family and contain both a PAZ and Piwi domain. These domains 
recognize dsRNA ends with a 3’ two-base overhang (MacRae et al., 2006). RISC binds to the 
mRNA and the miRNA present in the complex anneals to it, usually with imperfect base-pair 
(Krol et al., 2010). The annealing occurs between the seed region near the 5’ terminus in the 
miRNA strain (~ nucleotide 2-7) and the complementary sequence in the mRNA (Cai et al., 2009). 
Thus protein synthesis is inhibited by either translational repression or mRNA deadenylation 
with consequent degradation.    
In Giardia many pathways from fundamental cellular processes seem to be simpler 
when compared to other eukaryotic organisms. Transcriptional and translational expressions are 
extremely regulated in higher eukaryotes like Giardia. However, this protozoon has few 
consensus promoters and particularly short 3’ and 5’ UTRs (untranslated regions), meaning that 
regulatory sites for translational regulation may be less available (Saraiya et al., 2008). 
In Giardia intestinalis miRNA mechanisms occur slightly different from what was earlier 
described, since its RNAi (RNA interference) machinery comprise distinct components. Giardia 
contains a homologous of the ribonuclease protein Dicer, (GlDcr) which three-dimensional 
structure is resolved by X-ray crystallography. Giardia also presents an Argonaute-like protein 
(GlAgo), but no homolog for Drosha or Exportin-5 (Saraiya et al., 2008). GlAgo function and 
activity are still poorly understood, however a few studies provided evidence that this protein 
may be involved in miRNA-mediated translational repression (Kiriakidou et al., 2007; Saraiya et 
al., 2008).  
In 2008, a study project from César Prucca showed that the process of antigenic 
variation in Giardia lamblia is regulated by RNA interference. Several transcripts from the VSPs 
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are produced even though only one VSP transcript accumulates, which suggested that the 
mechanism involved in its regulation should be at post-transcriptional level (Prucca et al, 2008). 
The reduction of rdrp (RNA-dependent RNA polymerase) and dicer expression gave rise to a 
trophozoite population expressing more than one vsp in their surface, whereas silencing of 
Giardia ago resulted in the absence of viable clones, meaning that this protein is essential for 
cell viability. Thus, cells with downregulation of RNAi machinery are suitable for the production 
of a vaccine since they express several VSPs simultaneously (Prucca et al, 2008). 
There were identified six miRNAs in Giardia – miR2, miR3, miR4, miR5, miR6 and miR10 
– and all of them derive from small nucleolar RNAs (snoRNAs), except from miR4, which is 
derived from a canonical biogenic pathway mediated by GlDcr (Saraiya et al., 2013). From this 
miRNAs, regions 100nt upstream and 50nt downstream the stop codon were analyzed and only 
miR3 has not shown to have vsp mRNAs as putative target (Saraiya et al., 2014).  
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2. Thesis Project Background and Objectives 
 
 Previous experiments performed at Giardia’s research group at ICM were based on RNA 
sequencing of Giardia intestinalis transcriptome at several time points during in vitro interaction 
with intestinal epithelial cells (Caco-2). These experiments showed that among the highly 
expressed genes were several members of the HCP family. These results were in agreement with 
previous studies (Roxström-Lindquist et al., 2005; Ringqvist et al., 2011; Maayeh et al., 2012).  
As the biological functions of the High Cysteine Protein family is completely unknown, the Giardia 
group decided to begin its characterization in order to understand their role during in vitro 
interactions and therefore during disease. Several HCPs were cloned into expression vectors 
fused to an HA tag and transfected into Giardia parasites in order to follow their localization by 
antibodies against the tag. Almost all HCPs tested, presented a particular localization except for 
two HCPs (GL50508_91707 and GL50508_115066 annotated in GiardiaDB) which showed 
different patterns with time: nucleus and, later on, plasma membrane. 
Based on this, the first two objectives of this project were: 
a. to confirm that localization changes in these HCPs were really occurring in vitro, and 
b. the expression and purification of recombinant HCPs for the production of specific 
antibodies to avoid the use of transfected cells lines. 
As mentioned along the introduction of this thesis, HCPs protein family has several similarities 
with another protein family present in Giardia: variant-specific surface proteins (VSPs). Due to 
the high resemblances structure-wise between the proteins from these two families, it was 
hypothesized that HCP regulation could occur in a similar way of VSP regulation: by miRNA 
regulation. Starting from here, the third and last objective in this project is to:  
c. determine the presence of one or more regulatory elements of transcription by miRNAs 
in some HCPs sequences. 
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3. Material & Methods 
3.1 Material Sterilization 
All the material, culture media and solutions suitable to high temperature treatment 
methods were autoclaved at 121°C and 1 atmosphere, for 20 minutes. All termolabile solutions 
were sterilized by filtration using 0.20µm or 0.45µm sterile filters. 
3.2 Bacterial Strains and Plasmids 
In this project were used two strains of E. coli – TOP10 and BL21 origami. E. coli TOP10 
chemically competent cells were used to manipulate and clone the recombinant plasmid pEX5P-
CT/TOPO (Invitrogen™). E. coli BL21 Origami chemically competent cells were used in the 
expression of the high-cysteine proteins GL50803_91707 and GL50803_7715. The genotype of 
these two strains is described in Table 1.  
Table 1 Genotype from E. coli TOP10 and E. coli Bl21 Origami (Life Technologies, Genotypes of Invitrogen™ competent 
cells, 2014)  
E. coli Strain Genotype 
TOP10 
F – mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara 
leu) 7697 galU galK rpsL (StrR) endA1 nupG 
 BL21 Origami F – ompT hsdSB(rB–, mB–) gal dcm (DE3) 
 
E. coli TOP10 chemically competent cells are engineered in order to increase the 
transformation efficiency. This strain allows a stable replication of high-copy number plasmids. 
They have different features regarding their final genotype: hsdR for efficient transformation of 
unmethylated DNA from PCR amplifications, mcrA for efficient transformation of methylated DNA 
from genomic preparations, lacZΔM15 for blue/white color screening of recombinant clones, 
endA1 for cleaner DNA preparations and better results in downstream applications due to 
elimination of nonspecific digestion by Endonuclease I and recA1 for reduced occurrence of 
nonspecific recombination in cloned DNA. 
BL21 Origami cells are ideal for use with T7 promoter-based expression systems. This 
strain allows protein expression  The DE3 designation indicates the strains contain the DE3 
lysogen that carries the gene for T7 RNA polymerase under control of the lacUV5 promoter. IPTG 
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(Isopropyl β-D-1-thiogalactopyranoside) is required to induce expression of the T7 RNA 
polymerase. ompT indicates that the E. coli lack an outer membrane protease, reducing the 
degradation of heterologous strains and improving the recovery of intact recombinant proteins. 
pEX5P-CT/TOPO® (Invitrogen™) was the plasmid used to clone the proteins of study. This 
vector has a bacteriophage T7 promoter for high-level, inducible expression of the recombinant 
protein of interest in E. coli, C-terminal 6xHistidine fusion tag for detection and purification of 
recombinant proteins, TOPO® Cloning site for rapid and efficient cloning of Taq-amplified PCR 
products, ampicillin resistance gene for selection in E. coli and pUC origin for high-copy replication 
and maintenance of the plasmid in E. coli, as shown in the plasmid map in Figure 7. pEXP5-
CT/TOPO® vector is supplied linearized with single 3-thymidine (T) overhangs for TA Cloning® and 
Topoisomerase I covalently bound to the vector (pEXP5-NT/TOPO® and pEXP5CT/TOPO® TA 
Expression Kits, Invitrogen™, 2006). 
During PCR amplification Taq-polymerase adds a single deoxyadenosine (A) to the 3’ ends 
of PCR products. Since the linearized vector is supplied linearized with single 3’-T overhangs, the 
PCR inserts can efficiently be ligated with the vector.  
 
 
 
 
 
 
 
 
pAC plasmids carrying 91707 and 7715 genes were available in lab due to previous 
experiments performed by the group. These constructs were used to transfect Giardia 
expressing the 3xHA-tagged 91707 and 7715 proteins. This plasmid carries a puromycin N-
acetyltransferase gene as a selection marker for Giardia transfectants. The PAC-pBS gene is 
Figure 7. Map of pEXP5-CT/TOPO® (Invitrogen™, 2006).  
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flanked by 47 bp of the giardial glutamate dehydrogenase (GDH) promoter and a 123-bp 3’ 
untranslated region (UTR) from GDH inserted between KpnI and HindIII restriction sites 
(Jerlström-Hultqvist et al., 2012). 
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3.3 Fusion Tags 
3.3.1 Histidine Tag 
The polyhistidine tag is a DNA sequence coding for six to nine histidine residues. This tag 
is frequently used in vectors for production of recombinant N- or C-terminal tagged proteins. 
After expression in an adequate E. coli strain, his-tagged proteins can be purified since the 
sequence of histidine residues is able to bind to several types of immobilized metal ions, 
including nickel, cobalt and copper, under specific buffer conditions. The sequence, position 
and length of the tag can influence the rate of protein expression, the accessibility for binding 
the column, the solubility and activity of the protein. Besides this, there are anti-His-tag 
antibodies commercially available, allowing the detection of tagged proteins in assays such as 
Western Blot (Loughran & Walls, 2011).  
3.3.2 Hemagglutinin Tag 
Hemagglutinin (HA) is a surface glycoprotein from Influenza A virus responsible for 
binding sialic-acid present in the cells´ surface of the upper respiratory tract in mammals. The 
HA tag is derived from the HA-molecule corresponding to amino acids 98-106 (YPYDVPDYA). 
This tag is widely used in expression vectors in order to track or detect proteins or purify them, 
with the use of specific antibodies anti-HA tag. HA-tag does not appear to interfere with the 
bioactivity or the biodistribution of the recombinant protein (Merck Millipore™, 2014).  
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3.4 General Methods of Molecular Biology 
3.4.1 Primers Design 
Forward and reverse primers specific to 7715 and 91707 were design in order to amplify 
these genes from Giardia genomic DNA. Both genes sequences were extracted from GiardiaDB 
(GL50803_91707 and GL50803_7715). The signal peptide and transmembrane domain 
sequences were removed from the original gene sequences to prevent insolubility of the 
expressed proteins. The signal peptide corresponds to nucleotides 1-57 (19 aa) in both genes 
and the transmembrane domain corresponds to nucleotides 1917-1983 (22 aa) in 91707 and 
nucleotides 1890-1956 (22 aa) in 7715. Primers were analyzed using the online tool 
OligoAnalyzer 3.1 – Integrated DNA Technologies® (IDT®) and are shown in Table 6 in Appendix 
8.1. 
3.4.2  Polymerase Chain Reaction 
The DNA fragments of 7715 and 91707 were amplified from Giardia intestinalis 
Assemblage A genomic DNA by polymerase chain reaction (PCR). PCR was performed on an 
Arktik™ Thermal Cycler (Thermo Scientific™). Each PCR reaction contained 20ng of Genomic 
Giardia DNA, 0.6µL of 10mM dNTPs, 1.2µL of primer forward, 1.2µL of primer reverse, 6µL of 
Buffer High Fidelity 5x with MgCl2 (Thermo Scientific™), 0.5µL of Phusion Hot Start II High-
Fidelity DNA Polymerase (proof reading – Thermo Scientific™) and sterile water up to 30µL.  
The reaction comprised the following steps: denaturation and enzyme activation step: 
98°C for 5 minutes; 35 cycles of amplification, including a denaturation step at 98°C for 15 
seconds, an annealing step at the primer-specific melting temperature (see Table 6 in 
Appendix 8.1) and a extension step at 72°C for 1 minute and 20 seconds, followed by an extra 
extension step 72°C for 5 minutes. After this, the tubes were slightly centrifuged and 0.5µL of 
Taq DNA Polymerase (no proof-reading – Thermo Scientific™) and the reaction continued at 
72°C for 20 minutes in order to add the 3´-A overhang using the Terminal Transferase activity 
of the Taq polymerase. 
3.4.3  Colony-PCR 
Colony-PCR was performed in order to detect bacterial clones carrying the desired insert 
in the right orientation in the construct with pEX5P-CT/TOPO, hence detecting the positive 
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colonies. Each PCR reaction contained 0.4µL of 10mM dNTPs, 0.8µL of primer T7 forward, 
0.8µL of gene-specific reverse primer, 2µL of Taq Buffer with KCl 10x (Thermo Scientific™), 1.6 
µL of MgCl2, 0.2µL of Taq DNA Polymerase (no proof-reading – Thermo Scientific™) and sterile 
water up to 20µL. The tubes with the PCR mix were placed on ice and a TOP10 E. coli colony 
was added with sterile toothpicks both to each reaction tube and to a gridded numbered plate, 
in order to track the positive colonies after the reaction assessment in agarose gel 
electrophoresis.  
3.4.4 Agarose Gel Electrophoresis 
Electrophoresis in agarose gel is one of the most common techniques to evaluate the 
size of DNA or RNA fragments. The principle of this technique is based on the migration of 
nucleic acids fragments from a negative to a positive polo, since DNA is negatively charged in 
neutral pH. The fragments will migrate according to their size, meaning that small fragments 
will more easily cross the porous matrix produced by agarose in solution.   
The analysis of the DNA fragments was evaluated by electrophoresis in 1% Tris-
acetate buffer (TAE) agarose gel stained with SYBR® Safe DNA Stain (Invitrogen™). The ladder 
used for size quantification of the double –stranded fragments was GeneRuller™ 1kb DNA 
Ladder (Thermo Scientific™). DNA samples were loaded in the gel together with 1µL of 6X DNA 
Loading Dye (Thermo Scientific™) to help the settling of the sample in the well. 
The gels were visualized in Gene Genius Bio-Imaging System (SynGene™) and, in case of 
gel extraction, the bands were excised on a gel detection tray (Pharmacia Biotech™). 
3.4.5 DNA Extraction and Purification from Agarose Gel 
The extraction and purification of the interest DNA fragment was performed using 
GeneJET™ Gel Extraction Kit (Thermo Scientific™), which contains a silica-based membrane 
technology in the form of a convenient spin column.  
The DNA fragment of interest was excised from a 1% TAE agarose gel with a clean 
scalpel and placed in a microcentrifuge tube previously weighed. The tube was weighed once 
again after collecting the band of interest. Binding Buffer was added in a proportion of 1:1 
(100µL/100mg of agarose gel) to the gel slice and the mixture was incubated on a heat-block 
at 55°C for 10 minutes with slight shaking. After the gel slice was completely dissolved, the 
mixture was transferred to a GeneJET™ purification column and centrifuged for 1 minute. The 
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column was then washed with 700µL of Wash Buffer, centrifuged for 1 minute and dried at 
room temperature. The column was transferred to a clean microcentrifuge tube and 
incubated at room temperature for 2 minutes with 50µL of elution buffer. After centrifuge for 
1 minute, the purification column was discarded and the purified DNA was stored at -20°C.  
3.4.6 TOPO® Cloning Reaction  
The principle of the TOPO® Cloning Reaction is based on linkage of the  
Topoisomerase I from Vaccinia virus to duplex DNA at specific sites (CCCTT), which leads to 
the cleavage of the phosphodiester backbone in one strand (Shuman, 1991). The energy 
released in the cleavage is conserved by formation of a covalent bond between the 3′  
phosphate of the cleaved strand and a tyrosyl residue (Tyr-274) of topoisomerase I. Thus, the 
bond between the DNA and enzyme can subsequently be attacked by the 5′  hydroxyl of the 
original cleaved strand, reversing the reaction and releasing topoisomerase (Shuman, 1994).  
Ligation reaction was performed according to the protocol provided by Invitrogen™ 
(pEXP5-NT/TOPO® and pEXP5-CT/TOPO® TA Expression Kits). 0.5 to 4µL of fresh PCR product, 
in a final concentration no higher than 100 ng/reaction, 1µL of Salt Solution (supplied with the 
kit), sterile water up to a final volume of 5µL and 1µL of TOPO® vector are gently mixed and 
incubated for 5 minutes at room temperature. TOPO® Cloning Reaction can either be kept 
overnight at -20°C or used immediately.      
3.4.7 Preparation of Competent Cells of E. coli strains TOP10 and BL21 Origami  
E. coli TOP10 and BL21 Origami competent cells are able to take up foreign DNA during 
transformation process due to an increase of the permeability of the cell-membrane. 
Overnight cultures of both strains were set up and inoculated in 200mL of sterile LB. 
The flasks were incubated at 37°C with shaking till the cultures reach and Optical Density (550 
nm) of 0.4 (exponential growth phase). At this point, the culture was transferred to 50ml 
falcon tubes and spun down at 3000rpm, for 10 minutes at 4°C. Each pellet was resuspended 
in 20mL of ice-cold TFBI and centrifuged in the same conditions. The pellet was then 
resuspended in 2mL of TFBII and placed on ice for 15 minutes. The suspension was aliquoted 
in microcentrifuge tubes (100µL/tube) which were immediately frozen in liquid nitrogen. The 
cells were stored at -80°C. 
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3.4.8  Transformation of Competent E. coli strains TOP10 and BL21 Origami  
  Transformation is the process by which foreign DNA is introduced into a prokaryotic 
cell. Introducing plasmid DNA in bacteria has an important relevance for several studies, since 
storage and replication of plasmids are ensured. These plasmids carry a bacterial origin of 
replication, the gene of interest and an antibiotic resistance gene which works as a selectable 
marker for positive transformants. 
 Transformation reaction was performed according to the protocol provided by 
Invitrogen™ (pEXP5-NT/TOPO® and pEXP5-CT/TOPO® TA Expression Kits). pEXP5-CT/TOPO-
7715 and pEXP5-CT/TOPO-91707 were introduced in E. coli TOP10 cells and in BL21 Origami 
cells. 2µL of ligation reaction was added to 100µL aliquots of chemically competent cells and 
incubated on ice for 20 minutes. Cells were then heat-shocked at 42°C for 45 seconds on a 
heat-block and immediately placed on ice for 5 minutes. 500µL of LB were added to each tube 
and the cells were placed at 37°C with shaking for 1 hour. Finally, the cells were slightly spun 
down and plated in LB plates containing 100µg/ml and incubated o/n at 37°C. Control cells 
were transformed with pUC19 plasmid.  
3.4.9  Extraction of Plasmid DNA from E. coli strains TOP10 and BL21 Origami 
Transformed Cells 
Plasmid DNA from E. coli strains TOP10 and BL21 Origami transformed cells was 
extracted using GeneJET Plasmid Miniprep Kit (Thermo Scientific™). 5-10ml of bacterial 
culture was spun down at 3500rpm for 15 minutes. The supernatant was discarded and the 
pellet was gently resuspended in 250µL of resuspension solution and transferred to a 
microcentrifuge clean tube. 250µL of lysis solution was added and the solution was mixed by 
inversion, followed by the addition of 350µL of neutralization solution. The solution was mixed 
by inversion and centrifuged at 13000rpm for 5 minutes at RT.  The supernatant was 
transferred to a GeneJET™ spin column and centrifuged for 1 minute. The column was then 
washed twice with 500µL of Wash Buffer, centrifuged for 1 minute and dried at room 
temperature. The column was transferred to a clean microcentrifuge tube and incubated at 
room temperature for 2 minutes with 50µL of elution buffer. After centrifuge for 2 minutes, 
the spin column was discarded and the purified plasmid DNA was stored at -20°C. 
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3.4.10  DNA Sequencing 
 To verify the correct sequences of the cloned plasmids, samples of the plasmids were 
sent for sequencing at the Uppsala Genome Center. All the samples contained 450ng of 
plasmid together with efficient sequencing primers (4pmol/tube) and water to a final volume 
of 18µl. 
3.5 Culture conditions for Giardia intestinalis 
 
Giardia intestinalis, strain WB clone 6 (GL_50803) trophozoites were cultured in vitro in 
TYDK medium supplemented with 10% heat inactivated Bovine Serum (Gibco®) with a pH of 6.8 
and grown at 37°C in an incubator with 5% O2, according to Keister DB, 1983.  
TYDK media consists of  30 mg/ml Peptone (Becton, Dickinson and Company), 55.6mM 
Glucose (Sigma®), 34.2mM NaCl (Sigma®), 1.14mM L‐ascorbic acid (Sigma®), 5.74mM K2HPO4 
(Sigma®),  4.41mM  KH2PO4  (Sigma®),  11.4mM  L‐cysteine  hydrochloride  monohydrate 
(Sigma®) and 0.038mM ferric ammonium citrate (Sigma®), into filtered dH2O. The pH was 
adjusted to 6.8 by adding 4M NaOH. The medium was sterile filtered with a 0.45µm filter 
system and supplemented with 0.268mg/ml filtered bovine bile (Sigma-Aldrich®) in a final 
concentration of 1%. 
3.6 DNA extraction from Giardia intestinalis 
Cells from a confluent tube of G. intestinalis (1×107 cells) were harvest by centrifuge at 
3000rpm for 8 minutes. The supernatant was removed and the cell pellet was washed in 1ml of 
cold PBS to remove any media components by centrifuge at 2500rpm for 8 minutes once again. 
The pellet was resuspended in 500μl of lysis buffer including 50mM EDTA, 1% SDS and 10mg/ml 
Proteinase K. The resuspended pellet was later incubated at 56°C for at least 1 hour and mixed 
occasionally by vortexing. 20μl RNase A was added and the mixture was incubated for 20 
minutes at room temperature. To the tube were added 275μl of Phenol (pH 8), 275μl of Chisam 
(24:1 chloroform:isoamyl alcohol) and mixed carefully by vortexing for 20 seconds. The sample 
was centrifuged for 10 minutes at 13000rpm. The aqueous phase of the tube (upper phase) was 
removed and an equal volume of Chisam was added in it. After vortexing for 20 seconds and 
centrifuging the tube for 10 minutes at 13000rpm the aqueous phase was precipitated with an 
equal volume of isopropanol and followed by 10 minute incubation at room temperature. The 
                    
           MATERIAL & METHODS 
    
33 
 
tube was centrifuged for 10 minutes at 13000rpm, the supernatant was removed and the pellet 
was washed with 1ml of 70% cold ethanol and then centrifuged for 5 minutes at 13000rpm at 
4°C. The supernatant was removed and the pellet was air-dried and dissolved ddH2O (20-300μl 
depending on the amount of start material). The final concentration of genomic DNA was 
measured by NanoDrop®. 
3.7  Giardia Transfection  
A nearly confluent tube of G. intestinalis (80-90%) was placed on ice for 15 minutes to 
allow cell detachment. Cells were collected by centrifuging the tube at 2500rpm for 5 minutes. 
The pellet was resuspended in 300µl of TYDK and placed into a 4mm gap electroporation Gene 
Pulser® Cuvette (BioRad®) and placed on ice. To the cuvette, ~20µg the recombinant plasmids 
pAC carrying 91707 or 7715 were added, mixed with pipette and electroporated immediately. 
These plasmids were used in previous experiments by the lab team and were available for this 
experiment. The settings used for the electroporator Gene Pulser (Bio-Rad®) were: pulse in 
350V, capacitance in 960µF and resistance in 800Ω. 
After the electroporation the cuvettes were incubated on ice for 10 minutes and later 
transferred to culture tubes with 10 ml of warm TYDK media. The electroporated cells were 
grown at 37°C for 24 hours before 50μg/ml of puromycin (selection drug) was added. Every 
week, fresh media and selective drug was given to the transfected cells until they become 
confluent and stable. In order to avoid contamination during the cell cultivation, 100μg/ml of 
gentamicin was added to the culture tubes.  
3.8  Immunofluorescence of Giardia Transfectants 
In order to prepare the samples for immunofluorescence assay, one confluent tube of 
Giardia was used and put on ice for 10 minutes and centrifuged at 2500rpm for 5 minutes. The 
cell pellet was washed in PBS and centrifuged again at 2500rpm for 5 minutes. Next, the cell 
pellet was resuspended in 1ml of ice-cold HBS-glucose buffer (Hepes Buffered Saline) to wash 
away media components and centrifuged again at 2500rpm for 5 min. Thereafter, 25µl drops of 
cells were placed on poly-L-lysine coated "Diagnostic Microscope Slides" (Thermo Scientific®) 
with 10 wells. The cells were allowed to attach to the surface of the slide at 37°C for 10 minutes 
in a humidity chamber. G. intestinalis trophozoites were fixed with 2% paraformaldehyde (PFA) 
at 37°C for 30 minutes. The glycine was removed and 20µl of 0.1M Glycine in PBS was added to 
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the wells to quench any remaining traces of fixative. The fixative was removed and the wells 
were washed 2 times with PBS before 20µl of 0.2% Triton-X dissolved in PBS were added and 
incubated for 30 minutes at 37°C to permeabilize the cells. The solution was removed and 20µl 
of 2% BSA dissolved in PBS and incubated at room temperature during 1h or at 4°C o/n. 
After incubation, the blocking solution was removed and 20µl of Anti–HA monoclonal 
antibody (product no. H 9658, Sigma-Aldrich®) diluted 1:500 times containing the DNA stain 
4',6'diamidino-2-phenyldole (DAPI – 200mg/ml) 1% in the blocking buffer were added and 
incubated for 1 hour at room temperature. Next, the antibody was removed using vacuum 
suction and the wells were washed 4 times with 2%-BSA-PBS before 20µl of the secondary anti-
mouse antibody conjugated to Alexa 488 diluted 1:250 times in the blocking buffer were added 
and incubated for 1 hour at room temperature. The antibody was removed using vacuum 
suction and the wells were washed 5 times with PBS. In the final step, 3µl of mounting media 
Vectashield (Vector Laboratories®) were added and a cover slip was placed over the wells and 
sealed with nail varnish. The slides were stored at -20°C in darkness. The immunostained cells 
were examined with a Zeiss Axioplan2 fluorescence microscope and the images were processed 
using the software Axiovision Rel. 4.8. 
3.9 Long term storage of Giardia Transfectants  
80% confluent tubes of a Giardia transfectants were spun down at 2500rpm for 5 
minutes. Supernantant was discarded and the cell pellet was resuspended in 1ml of complete 
TYDK plus 10% DMSO (Dimethyl sulfoxide, Sigma-Aldrich®) and transferred to a well labeled 
cryo-tube (Nunc®). Stocks were stored at -80°C.   
3.10 Long term storage of Bacterial clones 
1 ml of transformed E. coli (TOP10 or BL21 Origami) o/n culture in LB 80% glycerol 
(Sigma®) in a final concentration of 15% glycerol. Glycerol prevents cell membrane damage and 
keeps the cells alive. The mixture is then transferred to a glass vial with metal lid properly 
labeled and stored at -80°C. 
 
 
                    
           MATERIAL & METHODS 
    
35 
 
3.11 Protein Expression and Purification 
3.11.1 Optimization of Bacterial Recombinant Protein Expression  
E. coli BL21 Origami cells carrying either pEXP5-CT/TOPO-7715 or pEXP5-CT/TOPO-
91707 construct were incubated o/n at 37°C with shaking in LB with 1% glucose and 0.1% 
ampicillin. The day after, these cultures were inoculated in a dilution of 1:20 in 500mL of LB 
with 1% glucose, 0.1% ampicillin and 0.1% MgSO4 and incubated at 37°C till they reach and 
OD600 of 0.8. At this point, 1ml samples were collected – labeled as non-induced samples – and 
1mM IPTG (Isopropyl β-D-1-thiogalactopyranoside) was added to the E-flasks in order to 
trigger induction. Protein induction was performed in three different conditions: o/n at room 
temperature, o/n at 4°C, 3 hours at 30°C and 3 hours at 37°C, with shaking. After induction, 
OD600 was measured once again and 1ml samples were collected – labeled as induced samples. 
The remaining culture was transferred to 50ml falcon tubes and centrifuged at 3500rpm for 20 
minutes. Supernatant was discarded after saving a 2ml sample and each pellet was 
resuspended in 5 ml of ice-cold resuspension buffer containing protease inhibitor cocktail 
tablets (Roche®). Resuspended pellets were added together in a final volume of 15ml and 
resuspension buffer was added up to a final volume of 25ml in each falcon. Different sets of 
buffers were used during the optimization of recombinant proteins expression and 
purification.  
3.11.2  Purification of Recombinant Proteins and Protein Quantification 
3.11.2.1 E. coli BL21 Origami Cell Lysis 
One of the most important steps when purifying recombinant proteins is the 
preparation of the bacterial lysate. The key is to determine the optimal conditions in order to 
take full advantage of cell lysis and increase the yield of extracted recombinant protein and, 
on the other hand, minimize protein oxidation events, proteolysis and contamination with 
genomic DNA (Structural Genomics Consortium et al., 2008). 
Bacteria sonication of was performed using a vibracell™ sonicator (Sonics®). The 
resuspended pellets (in a volume of 25 ml) were sonicated with a 6mm tip, during 10 minutes, 
with a pulse of 10/10 and amplitude of 40%. 1ml samples were collected – labeled as total 
sonicated – and the falcon tubes were centrifuged at 4000 rpm during 1 hour at 4°C. The 
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supernatant was transferred to a clean 50ml falcon and the remaining pellet was resuspended 
in 1ml of resuspension buffer.     
3.11.2.2 SDS–PAGE Gels 
SDS-PAGE (Sodium dodecyl sulfate Polyacrylamide gel electrophoresis) is a technique 
that allows the electrophoretic separation of proteins and nucleic acids according to their 
mobility. SDS detergent denatures proteins, which lose their tridimensional structure and 
native properties, and negatively charges the protein surface. Since the proteins charge is no 
longer a determinant factor for its separation, these molecules can be separated by size, 
migrating from the negative to the positive electrode. The concentration of SDS in the gel is 
chosen according to the size of the proteins that one intends to separate: proteins with a 
higher molecular weight need higher SDS concentration to denature.  
Mini-PROTEAN® TGX Stain-Free™ pre-casted gels (Bio-Rad®) were used to separate the 
study proteins. These gels are suitable to separate protein with a wide range of molecular 
weight (kDa). Proteins lysates and fraction were collected after cell disruption and protein 
purification by Immobilized Metal Affinity Chromatography (IMAC). All the samples were 
treated with 1.2µL of 2-mercaptoethanol to reduce disulfide bonds and, consequently, disrupt 
protein tertiary structure, and 7µL of 4x Sample Buffer (Bio-Rad®). The samples were boiled at 
98°C during 10 minutes. The tubes were slightly spun down and 30-50µL of each samples were 
loaded in the gel wells. The running occurred at 100V during 1 hour. The gel was disassembled 
and stained with Coomassie Blue reagent during 1h with shaking or used for western blot 
method. 
3.11.2.3 Western Blots 
Western blotting was performed using standard techniques. The proteins separated by 
SDS-PAGE gel was transferred to a FluoroTrans® PVDF (Polyvinylidene Flouride) membrane 
(Pall Life Sciences), previously activated in methanol for 5 minutes followed by equilibration in 
transfer buffer- The membrane was placed on top of the gel stacked between pads and 
filterpapers. The stack was placed in 1x Transfer buffer and the transfer was performed at 
100V for 1 hour at room temperature with cooling and continuous stirring of the buffer for 
homogenous cooling. The membrane was then blocked using 3 % non-fat dry milk in Tris 
buffered saline (TBS) containing 0.1 % Polyoxyethylenesorbitan monolaurate, Tween20 
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(SigmaAldrich®) to reduce unspecific binding of the antibodies. The membrane was blocked 
for 1 hour at room temperature followed by washing three times for five minutes each in TBS-
T. The membrane was incubated with Anti-His6 antibody (product no. 04905318001, Roche®) 
as the primary antibody which was diluted 1:6000 in TBS-T for 1 hour at room temperature. 
Thereafter the membrane was washed as previously followed by a 1 hour incubation with the 
secondary antibody, Anti-mouse coupled with horseradish peroxidase (HRP) (product no. 
P0161, Dako®) diluted 1:20 000 in TBS-T. After one hour incubation the membrane was 
washed as before with TBS-T. Blots were developed using Clarity™ Western ECL Substrate 
(Bio-Rad®) according to the manufacturer’s instructions. 
3.12 Immobilized Metal ion Affinity Chromatography (IMAC)  
Immobilized metal ion affinity chromatography (IMAC) was the method used to purify 
the his-tagged proteins. The purification was performed in a NGC™ Cromatography System 
(BioRad®) with a HisTrap FF column (GE Healthcare®) of 1ml capacity.  HisTrap FF column is 
prepacked with precharged Nickel Sepharose 6 Fast Flow. Nickel Sepharose 6 Fast Flow consists 
of 90µm beads of highly cross-linked agarose, to which a chelating ligand has been immobilized. 
This chelating ligand is charged with Ni2
+ ions. This column has a high binding capacity, of 
approximately 40 mg/ml medium.  
Histidine has a pKa of approximately 6.0, meaning that at pH 8.0 this amino acid will be 
negatively charged. Due to the high content of negatively charged histidines present in the His-
tag, there is a high affinity to bind the agarose matrix covered by Ni2
+ ions. The procedure starts 
with the equilibration of the column with binding buffer, which is the same buffer where the 
lysate is resuspended. This buffer is previously treated with DNAse (Thermo Scientific™), RNAse 
(Thermo Scientific™) and protease inhibitors (cOmplete Protease Inhibitor Cocktail Tablets, 
Roche®). The sample is then applied to the system at a flow rate of 1ml/minute to allow the 
binding of the recombinant proteins.The column is washed with wash buffer to remove the 
unspecific and weakly bound proteins and components of the mixture. The final step is the 
recovery of the his-tagged protein by applying the elution buffer with high concentration of 
Imidazole, since this compound competes for coordination sites on Ni2
+ displacing His-tagged 
protein from the matrix. The composition of all buffers used in the purification of 91707-His and 
7715-His can be found in Table 2. The purification profile was analyzed using ChromLab™ 
Software. 
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3.13 Bioinformatics Analysis 
The 3’end and 3’UTR sequences of the 86 annotated HCP genes were downloaded from 
GiardiaDB.org. 50 nucleotides from the 3’ end sequences and 100 nucleotides from the 3’UTR 
sequences we analyzed. The 86 3’end-3’UTR sequences were aligned using the alignment tool 
Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/). From these alignments, the HCPs 
were grouped according to the homology between the 3’end-3’UTR sequences. In each HCP 
group, the 3’end and 3’UTR were align using the same tool. To evaluate the potential presence of 
miRNA regulation sites in the 3’end and/or 3’UTR of these HCPs, the seed region of 50 putative 
miRNAs from Giardia were align with the HCP groups. 
 
 
 
 
 
 
Set 1 Set 2 
Resuspension
/Binding 
Buffer 
HEPES 100mM pH 8; DDT 
2mM; NaCl 200mM; Triton 
1%; Glycerol 20%; 10mM 
Imidazol; Proteinase 
Inhibitors.  
Resuspension/B
inding Buffer 
HEPES 100mM pH8; NaCl 200mM; 
DTT 1mM; Glycerol 10%; Imidazole 
5mM; DNAseI-RNAseA 20ug/ml 
each. 
Wash Buffer 
DDT 2mM; NaCl 200mM; 
HEPES 100mM pH 8; Triton 
1%; Glycerol 20%. 
Wash Buffer 1 
HEPES pH8 100mM; NaCl 300mM; 
DTT 1mM; Glycerol 10%; Imidazole 
5mM. 
Wash Buffer 2 
HEPES pH8 100mM; NaCl 500mM; 
DTT 1mM; Glycerol 10%; Imidazole 
10mM. 
Elution Buffer 
DDT 2mM; NaCl 200mM; 
HEPES 100mMpH 8; Triton 
1%; Glycerol 20%. 
Elution Buffer 
HEPES pH8 100mM; NaCl 500mM; 
DTT 1mM; Glycerol 10%; Imidazole 
500mM. 
Desalting Buffer 
HEPES pH8 100mM; NaCl 500mM; DTT 1mM;  
Glycerol 10%. 
Table 2. Composition of the different buffers used in the purificartion of the his-tagged proteins.  
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Figure 8. Schematic description of 
Stem Loop qPCR using TaqMan 
probe [Adapted from: Chen et al., 
2005]. 
3.14 Stem Loop-qPCR 
Stem Loop Quantitative Real-Time PCR is a technique used to detect and quantify the 
expression levels of miRNAs. This technique comprises two main steps schematically described in 
Figure 8: the first step is a Stem-Loop reverse transcript reaction where cDNA is produced with 
the use of a stem-loop primer which anneals in the 3’ end of the 
miRNA strand. The second step is a Real-Time Polymerase Chain 
Reaction where the amount of DNA is measured after each cycle 
via fluorescent dyes. The fluorescent signal is directly 
proportional to the number of PCR product molecules – 
amplicons (Chen et al., 2005). 
Two SLRT-qPCR reactions were performed: the first one 
with all sets of primers present in Table 7 in Appendix 8.1 and 
total RNA from Giardia trophozoites; the second with mir6 and 
mir6-control sets of primers and total RNA extracted from 
trophozoites during interaction with intestinal epithelial cells (IEC) 
in different time points. All RNA samples had been extracted and 
prepared prior to my arrival in the project.  
Each SLRT reaction contained 50ng of DNaseI-treated total RNA, 0.5µL of 10mM dNTP 
mix, 2µL 10X first-strand Buffer, 2µL 50mM MgCl2, 2µL 0.1M DTT, 0.1µL RNAseOUT, 0.25µL of 
SuperScript® III Reverse Transcriptase (all from Invitrogen™) and H2O up to 19µL. 1µL of the 
correspondent 1mM SLRT-primer previously denaturated at 65°C for 5 minutes is added to the 
reaction tube. Reaction without SuperScript® III Reverse Transcriptase (-RT) and without 
template (-T) were also prepared. The reactions comprised the following steps: 16°C for 30 
minutes, 60 cycles of 30°C for 30 seconds, 42°C for 30 seconds and 50°C for 1 second, and 85°C 
for 5 minutes. The reaction was ready for qPCR.  
Each qPCR reaction SuperScript® III Reverse Transcriptase (+RT qPCR) contained 1µL of 
10mM Fw primer, 1µL of 10mM Rv primer, 10 µL of SYBR® Green Master Mix (BioRad®), 6µL of 
sterile dH2O and 2µL of RT product.  The 96-well plate was sealed and placed in a StepOnePlus™ 
Real-Time PCR System and analyzed with StepOne™ Software from Life Technologies™. The 
reactions comprised the following steps: 95°C for 5 minutes, 40 cycles of 95°C for 5 seconds and 
60°C for 10 seconds; for melting curve analysis, samples were denatured at 95°C and cooled to 
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65°C at 0.2°C/second. Fluorescence signals were collected at 530nm continuously from 65°C to 
95°C at 0.2°C/second.  
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4.  Results and Discussion 
4.1 Evaluation of expression levels and localization of HCPs transfectants 
 
 As mentioned in section X – Project Thesis Background and Objectives, the Giardia 
intestinalis transfectant 91707-HA showed a change in localization of the overexpressed tagged 
protein. Transfectants 91707-HA presented different protein localization when defrosted closer 
to or further from the transfection date, termed 91707-A and 91707-B respectively. Starting from 
here, these transfectants were followed by immunofluorescence assay (IFA) in two different 
approaches. Firstly, the cells were followed during 3 days and immunofluorescence assay was 
performed two times per day (within 8h). Considering the generation time of Giardia around 8h, 
during this period 9 generations were followed. A few days after this, it was decided to follow 
these transfectants for a longer period, covering more generation of the parasite. Thus, the same 
transfectants were followed by IFA, but this time only one time per day during 13 days. IFA was 
performed in the first 6 days, in day 8, day 10 and day 13 and a total of 37 generations were 
followed. After these two assays, the cells were counted and evaluated according to the cellular 
localization of the protein. The results from these counting are showed in the graphs from Figures 
9 and 10. These values were obtained by counting two slides from each transfectant and 
generation. 
Figure 9. Cell Counting for Protein Localization of 91707-HA A Giardia transfectant.  
N/NP – Nucleus/Nuclear Periphery; ER – Endoplasmic Reticulum; PM – Plasma Membrane; PM/PVs – Plasma 
Membrane/Peripheral Vacuoles; UKN/No Signal – Unknown localization/No signal. 
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 Looking at the cell counting results shown in Figure 9 it can be conclude that the main 
patterns of cell localization for 91707-HA protein are plasma membrane and peripheral vacuoles 
(PM/PVs) in A transfectant. In generations 1 and 4 there are cells that show exclusively plasma 
membrane localizations, which was never detected alone again along the 37 generations 
followed. In generation 37 there were very few cells in the slides and the results obtained for this 
generation did not reflect the real scenario of the culture at this stage, whereby the cell counting 
was not valid. 
 
Regarding the cell counting results for 91707-HA B transfected trophozoites present in 
the graph on Figure 10, it can be seen that the predominant localizations for the recombinant 
protein are nucleus (N/NP) and endoplasmic reticulum (ER), in opposition to transfectant A.  
In Table 3 is present an example of IFA pictures of the localization of 91707-HA in 
transfectants A and B along the several followed generations. 
 
  
Figure 10. Cell Counting for Protein Localization of 91707-HA B Giardia transfectant.  
N/NP – Nucleus/Nuclear Periphery; N/ER – Nucleus and Endoplasmic Reticulum; ER – Endoplasmic Reticulum; ER/CYT 
– ER and Cytoplasm; PM – Plasma Membrane; PM/PVs – Plasma Membrane/Peripheral Vacuoles; UKN/No Signal – 
Unknown localization/No signal. 
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Table 3. Localization of 91707-HA in Giardia intestinalis transfectants A and B.  
  
 Generation                                              91707-HA A                                                                                                                   91707-HA B 
 
1 
 
 
 
 
 
4 
 
 
 
 
 
7 
Plasma Membrane                                  
Endoplasmic Recitulum/Nucleus                                  
Endoplasmic Recitulum  
Endoplasmic Recitulum/Nucleus                                  
Plasma Membrane                                  
Endoplasmic Reticulum/PVs                                  
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Table 4 (cont.). Localization of 91707-HA in Giardia intestinalis transfectants A and B.  
 
10 
 
 
 
 
 
 
13 
 
 
 
 
 
 
16 
Endoplasmic Recitulum/Nucleus                                  
Endoplasmic Recitulum/Nucleus                                  
Endoplasmic Recitulum/Nucleus                                  
Plasma Membrane/PVs                                  
Plasma Membrane/PVs                                  
Plasma Membrane/PVs                                  
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Table 5 (cont.). Localization of 91707-HA in Giardia intestinalis transfectants A and B.  
 
 
 
22 
 
 
 
 
 
 
28 
 
 
 
 
 
37 
Plasma Membrane/PVs                                  
Plasma Membrane/PVs                                  
Plasma Membrane/PVs                                  
Endoplasmic Recitulum                                 
Endoplasmic Recitulum/Nucleus                                  
Endoplasmic Recitulum/Nucleus  
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The pattern of cellular localization for 91707-HA in transfectant A is the plasma 
membrane. This localization is believed to be the correct one for this protein, based on the results 
with the freshly transfected cells obtained from early experiments in the laboratory. Transfectant 
A is referred as the culture passage closer to the date of transfection. On the other hand, there is 
different scenario regarding transfectant B. This transfectant has been passed for a longer period 
of time, using a small amount of initial culture each time. Transfectant B showed mainly ER and 
nucleus localization for 91707-HA to later change into plasma membrane. One hypothesis to 
explain this phenomenon is the adaptation of the trophozoites to the overexpression of 91707-
HA. This means that somehow, along several generations, this transfectant is trying to regulate 
the expression of the HCP to avoid the high loading of the recombinant protein to the plasma 
membrane. It is to remember that the tagged protein is expressed episomally while the cell still 
carries the other four chromosomal copies of the gene. What it is observed in transfectant B could 
be the actual biosynthesis and transport of the 91707 HCP, being synthesized in the nuclear 
periphery and delivered into the ER for transport to the plasma membrane, as its final cellular 
localization. If this is true, there is no signal of 91707-HA in the plasma membrane when the 
nuclear periphery is synthesizing the protein. This means that there is a protein turnover not by 
internalization and degradation but probably by secretion of 91707 to the media for then 
synthesize more of the protein. To prove this a specific antibody is needed to be able to detect 
also the 91707 protein generated from the chromosomal copies of the gene not carrying the tag. 
The chromosome versions of the protein might be present in the plasma membrane when the 
tagged protein is being synthesized. If this is the situation, then it means the cell is expressing 
91707 from different genomic loci and became able to regulate the episomal copy in the same 
manner as the chromosomal ones. 
In both transfectants, the cell counting revealed a high number of cells with no signal 
detected when compared to the total number of counted cells. These cells in fact might be 
expressing the untagged 91707 protein translated from the chromosomal genes, similar to the 
above explanation. 
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4.2 Recombinant High Cysteine Proteins Expression and Purification  
 
Two HCPs GL50508_91707 and GL50508_7715 were selected for production and 
purification to produce an AB (tool) and be used in functional assays with G. intestinalis 
trophozoites. From now on, the proteins will be mentioned as 7715-His and 91707-His. 
4.2.1 Cloning of 91707 and 7715 for Recombinant Protein Expression  
The first step of this part of the project was the construction of the vectors carrying 
91707 or 7715. pEXP5-CT/TOPO® (Invitrogen™) was the chosen vector for this cloning containing 
a Histidine tag on its sequence, which will be fused to the c-terminal region of the protein once 
expressed. Both 91707 and 7715 gene sequences did not contain the signal peptide and 
transmembrane domain fragments. Therefore, an ATG codon was added in the 5’ region of the 
forward primer. PCR reactions were performed in order to amplify the desired gene sequences 
from Giardia genomic DNA. The expected band sizes for the genes without the referred fragments 
are 1806bp for 91707 and 1836bp for 7715. PCR products were obtained according to the 
description in Section 3.4.2 and its sizes could be compared to the expected ones by visualization 
in 1xTAE agarose gel. In Figure 11 are shown the PCR products from the amplification reaction.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lanes 2 and 3 show the PCR products of 7715 fragment. PCR products in these lanes are 
localized between the 1.5kb and 2.0kb bands showed by the ladder (lane 1), meaning that the 
amplified products have the expected size. There can also be seen some extra bands lower in 
Figure 11. PCR products from Giardia genomic DNA in 1% 
agarose gel. 1 – GeneRuler™1kb DNA Ladder; 2 and 3 – 7715 
fragment; 4 and 5 – Empty lanes; 6 and 7 – 91707 fragment.  
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these two lanes, meaning that some unspecific amplification may have occurred. However, these 
accessory bands will not interfere with the amplified fragment, since the latter will be excised by 
GeneJET™ Gel Extraction Kit (Section 3.4.5). 
Lanes 6 and 7 show the PCR products of 91707 fragment. Once again, the bands are 
found slightly below the 2.0kb band showed in the ladder lane, meaning that these fragments 
have the expected size. The four bands obtained from the PCR reaction show high intensity. The 
concentration of DNA obtained after performing GeneJET™ Gel Extraction Kit was 74ng/µL for 
7715 and 89ng/µL for 91707. These numbers represent a good recovery yield in gel extraction 
recovery.  
After gel-purify 91707 and 7715 fragments obtained by PCR, these DNA sequences were 
cloned into pEXP5-CT/TOPO® vector according to the description in Section 3.4.6 and E. coli 
TOP10 strain was transformed with the recombinant constructs, as mentioned in Section 3.4.8. To 
analyze the transformants, colony-PCR was performed as mentioned in Section 3.4.3 in order to 
evaluate the orientation of the gene in the vector. This is possible since the two primers used in 
the PCR reaction anneal with different sequences: one of the primer is specific for the vector and 
the other for the insert. 10 colonies from each construct transformation were randomly selected 
for colony-PCR. The 20 reactions were detected and analyzed in 1% agarose gel, as is shown in 
Figure 12.  
 
 
 
 
  
 
Figure 12. Colony-PCR products of pEXP5-CT/TOPO®-7715 and pEXP5-CT/TOPO®-91707 
constructs extracted from E. coli TOP10 transformants in 1% agarose gel.  
1 – GeneRuler™1kb DNA Ladder; 2-11 – 7715; 12-21 – 91707. 
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In the lanes corresponding to 7715 fragment (lanes 2 to 11), no bands with the expected 
size, ~ 1.8kb, can be detected. Essentially, in all lanes are visible intense bands of primer dimer 
with a size lower than 250bp. Primer dimer occurs when primer molecules hybridize and DNA 
polymerase amplifies this dimer, leading to the inhibition of the amplification of the target DNA 
sequence.   
In the lanes corresponding to 91707 fragment (lanes 12 to 21), bands with an 
approximate size of 2.0kb are visible. The extension with the T7 forward primer used in the 
amplification adds 76 nucleotides from the vector to the fragment, increasing the expected size to 
~ 1.9kb, in agreement to what is seen in Figure 12. In lane 12 a clear and intense band is visible 
while in lanes 16 and 17 the bands are faint but they are present in the correct size position. 
These three clones, 1, 5 and 6 respectively, were confirmed to be positive ones by Sanger-
sequencing (Uppsala Genome Center).   
Since no positive clones were detected for pEXP5-CT/TOPO®-7715 construct, a new 
TOPO® ligation reaction and E. coli TOP10 transformation were performed and 20 new colonies 
were tested by colony-PCR. The results from the colony-PCR were analyzed in 1xTAE agarose gel, 
as shown in Figure 13.  
 
 
 
 
 
 
 
Figure 13. Colony-PCR products of pEXP5-CT/TOPO®-7715 construct extracted from E. coli 
TOP10 transformants in 1% agarose gel.  
1 – GeneRuler™1kb DNA Ladder; 2-21 – 7715. 
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 In lanes 3 and 4 is visible an artifact band slightly above the 1.0kb band showed by the 
ladder. In lane 8, a very faint band can be detected around 2.0kb, shown by the black arrow. This 
clone, termed clone 7, was confirmed to be positive by Sanger-sequencing.  
After confirming that the putative positive clones from pEXP5-CT/TOPO®-7715 and 
pEXP5-CT/TOPO®-91707 were, in fact, positive, these constructs were transformed into the 
expression E.coli strain BL21 Origami, as described in Section 3.4.8. We assumed that all colonies 
present in the plates were positive, given that they acquired the resistance to ampicillin only by 
internalizing the recombinant TOPO® vector. 
4.2.2 Optimization of protein induction and expression 
E. coli BL21 Origami transformants with pEXP5-CT/TOPO®-7715 and pEXP5-CT/TOPO®-
91707 were induced to express the respective proteins according the conditions described in 
Section 3.11.1. These inductions were assessed in 10% SDS-PAGE followed by Western Blot or 
Coomassie Blue staining. These recombinant proteins, 7715-His and 91707-His, have a molecular 
weight of 66.2 kDa and 65.6 kDa, respectively. 
Different conditions were tested to induce the expression of proteins 91707-His and 
7715-His. In Figure 14 are represented the results from the first induction of proteins expression, 
which occurred at 37°C during 3h and 1mM IPTG.  
 
 
 
 
 
 
 
 
 
 
 Figure 14. SDS-PAGE analysis of the expression of His tagged proteins. A – Comassie gel; B – Western blot.  
NI – Non Induced; I – Induced; SOL – Soluble fraction; PEL – Insoluble fraction; L – PageRuler Prestained Protein 
Ladder. 
91707-his 7715-his 91707-his 7715-his 
kDa 
170 
100 
70 
55 
35 
25 
15 
10 
130 
40 
 NI      I      SOL     PEL    L    NI       I      SOL    PEL        NI     I    SOL     PEL    L       NI        I     SOL  PEL 
A B 
                    
                 RESULTS & DISCUSSION 
                                                      
51 
 
In the Coomassie gel from Figure 14-A the lanes corresponding to 91707-His samples a 
band between the 55 kDa and 70 kDa in the induced sample is present as indicated by the black 
arrow. This meant that the induction of 91707-His might have worked. However, in the western 
blot corresponding to the induced sample (Figure 14-B) the His-tagged protein does not seem to 
appear. In the soluble fraction, there is a faint band in the correct molecular weight position (~ 
60kDa), which is not confirmed by the western blot. On the other hand, in the insoluble fraction 
there is present a strong and distinct band in the same position that also shows up in the western 
blot, meaning that 91707 was expressed in the inclusion bodies. Inclusion bodies consist in 
aggregates of denaturated protein in the form of particles. Usually, the aggregated components 
belong to the organism of which the expressed recombinant protein is native from. The rest of 
the bands observed in the Blot represent background given by the His-tag antibody, since 
histidine is present in several proteins. Additionally, the overexposure of the membrane in the 
detector increases the detected signal.  
One explanation for 91707-His not giving a signal in the induced samples by Western 
Blot could be that the protein is not highly expressed after induction and, therefore, not detected 
by the anti-his tag antibody. However, the presence of a highly intense band with the expected 
molecular weight in the insoluble fraction supports the conclusion that there was an induction; 
although, the protein is insoluble.  
Figure 15. SDS-PAGE analysis of the expression of 91707-His at 30°C and room temperature. A – Coomassie Gel; B 
– Western Blot.  
NI – Non Induced; I – Induced; SOL – Soluble fraction; PEL – Insoluble fraction; L – PageRuler Plus Prestained Protein 
Ladder. 
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Regarding the lanes corresponding to 7715-His samples, does not seem to be a 
difference between the non-induced and the induced samples, both in Coomassie gel and 
western blot. Once again, there is a distinct band around 60 kDa present in the insoluble fraction, 
which is confirmed to be the His-tagged protein in the western blot. Thus, the expression of this 
protein also led to the formation inclusion bodies. In the non-induced, induced and soluble 
fraction samples there are present some accessory bands which represent unspecific antibody 
binding.  
The induction of 91707-His and 7715-His expression was performed in different 
conditions from the ones adopted in the first induction in order to assess if decreasing the 
temperature would avoid the formation of inclusion bodies. The Coomassie gels and Western 
Blots from these inductions are represented in Figures 15 and 16. 
 In Figure 15-A is shown the Coomassie gel from the induction of 91707-His at 30°C and 
room temperature o/n. The expression of the protein in different conditions was successful. A 
distinct band, indicated by the black arrow, with a molecular weight around 60kDa can be seen in 
the lane corresponding to the induced sample. This is both verified in the Coomassie gel and in 
the Western Blot, in opposition to what happened with the first induction. However, the protein 
is still being expressed with the formation of inclusion bodies in both conditions, similarly to what 
was verified in the induction at 37°C. Apparently, the decrease of temperature did not prevent 
the formation of inclusion bodies.       
Figure 16. SDS-PAGE analysis of the expression of 7715-His at 30°C and room temperature. A – Coomassie Gel; B – 
Western Blot.  
NI – Non Induced; I – Induced; SOL – Soluble fraction; PEL – Insoluble fraction; L – PageRuler Plus Prestained Protein 
Ladder. 
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In the Coomassie gel from Figure 16-A is shown the expression of 7715-His induced at 
30°C and room temperature. In the induced samples from both conditions, there is a band with a 
molecular weight around 60kDa. In the soluble fraction from the 30°C induction it is present a 
band in the correct molecular weight position, potentially corresponding to the His-tagged 
protein. The results observed in the Coomassie Gel are confirmed by Western Blot, shown in 
Figure 16-B. The interest bands in the induced and insoluble samples are indicated with white 
arrow. Once again, the protein seems to be expressed on its insoluble form.  
Overall, the expression of 91707-His and 7715-His was higher at 30°C and RT when 
compared to the one at 37°C. Unfortunately, the insolubility issue of both proteins was not solved 
with the decrease of the temperature during the inductions. Facing this problem, the first 
approach to solubilize the proteins was performed using 8M urea. However, the solubilization of 
the protein was not complete and a high amount of the protein fractions was still insoluble. 
Additionally, the use of high concentration of Urea could interfere with the process of purification 
of the his-tagged proteins. The second approach to solubilize the protein was the improvement of 
cell sonication. In the results from one of the several protein inductions performed, part of the 
protein appeared in the soluble form, as it can be seen in Figure 17. Starting from here, the 
initiative to optimize cell sonication in order to obtain the proteins in their soluble form was 
thought of.   
 
      
 
 
 
  
Figure 17. Western Blot 91707-His induction at RT: sonication 
optimization. L – PageRuler Plus Prestained Protein Ladder; NI – Non 
Induced; I – Induced; PEL – Insoluble fraction; SUP – Soluble Fraction. 
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4.2.3 Evaluation of protein purification by NGC™ Chromatography  
The purification of 91707-His and 7715-His was made when the proteins were finally 
produced on their soluble form. The results from the first purification of the his-tagged proteins 
are shown in Figures 18 and 19. In the Coomassie gel from Figure 18, in the lanes corresponding 
to the flowthrough (FT) and column washes (5 and 20) there is high content of protein that is not 
binding to the column matrix. In the lanes corresponding to proteins elution fraction, 46 to 55, it 
is present a very thin band with the expected molecular weight for 91707-his, indicated by the 
black arrow. In the Western Blot, Figure 18-B, there is a distinct band with the expected molecular 
weight in each lane from protein fraction, indicating that 91707-his was purified. However, similar 
bands to these ones are also faintly present in the flowthrough and column washes fraction, 
meaning that this buffer should be modified in order to wash unspecific unbound proteins 
without removing the interest his-tagged protein. Additionally, the wash volume should be 
increase to make sure that a higher amount of unspecific bound protein and components are 
removed before the elution of 91707-His.  
In Figure 19-A is shown the Coomassie gel from the purification of 7715-His by IMAC. It 
is worth to mention that the induced BL21 Origami culture for the expression of this protein used 
for this purification did not show to be positive. Thus, this purification was performed in a blind 
way, in case the induction turned out to be positive due to a misevaluation. As expected, both 
Coomassie gel and Western Blot did not reveal the presence of 7715-His in the eluted protein 
fractions or, actually, in any other fractions. Do to all the issues associated to this gene that were 
Figure 18. SDS-PAGE analysis of the purification of 91707-His by IMAC. A – Coomassie Gel; B – Western Blot.  
FT – Flowthrough; 5 and 20 – Wash Fractions; 46-55 – Protein Elution Fractions; L – PageRuler Plus Prestained Protein 
Ladder. 
   FT        5        20       46       L        48      49      50        51      
55 
   FT       5       20      46        L       48      49      50      51      
55 
A B 
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faced during the production of 7715-His, it was decided to move forward and optimize exclusively 
the purification of 91707-His.  
At this point, more bacteria culture was induced and processed in order to perform a 
new purification of 91707-His and evaluate the purification profile with the new set of buffers.  
The composition of these buffers can be found in Table 2 (Section 3.12). Triton was a 
component excluded from the primary set of buffers. Triton is a detergent usually used in 
particular protein purifications. It helps cell lysis and solubilization of proteins by disrupting 
lipid membranes, not affecting the biological activity of the protein. Since one managed to 
have 91707-His in its soluble form, the main function of the detergent was no longer needed. 
Besides this, the detergent will also be present in the protein fractions after elution, helping 
the protein to be stable. However, to be sent for antibody production, the protein should be 
stable in a buffer without components that may harm the animal during immunization. Thus, 
the Triton would have to be removed from these buffers, which could lead to the precipitation 
of the protein due to loss of stability. For this new purification two different wash buffers were 
prepared, with increasing concentration of NaCl, to assess if more unspecific bound proteins 
could be removed without eluting the his-tagged protein. The concentration of Imidazole was 
also increased within these buffers in order to remove the unspecific protein histidine bound.  
 FT        5       19     22    37   39     40     41    43     L  FT     5     19    22    37   39     40     41    43     L 
kD
a 250 
100 
70 
55 
35 
25 
15 
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130 
Figure 19. SDS-PAGE analysis of the purification of 7715-His by IMAC. A – Coomassie Gel; B – Western Blot.  
FT – Flowthrough; 5, 19 and 22 – Wash Fractions; 37-43 – Protein Elution Fractions; L – PageRuler Plus Prestained 
Protein Ladder. 
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In Figure 20 it is present the result from the purification of 91707-His when 250ml of 
culture were processed.  In the lanes corresponding to the clear protein lysate and Flowthrough in 
the Coomassie gel there is a high protein content, which results in a huge background showed in 
the Western Blot. When looking at the wash fractions with buffers 1 and 2, the ones 
corresponding to washes with buffer 2 contain two faint bands, being the lowest one in the 
molecular weight corresponding to 91707-His, around 60 kDa, meaning that some of the protein 
could had been eluted. However, there is no detection in the Western Blot from either one of 
these bands, which indicates that the increase in concentration of NaCl and Imidazole were 
sufficient to elute unspecific bound proteins without washing out the his-tagged protein. 
Additionally, there are no bands present in the fraction from the wash with buffer 1, meaning that 
the concentration of these two components in this buffer is not adequate to properly wash the 
column. Finally, in the protein fractions samples there are present two bands with similar 
molecular weight seen in the Coomassie gel, which are equally detected in the Western Blot. The 
presence of these two bands may indicate protein degradation, indicating that the histidine tag is 
present in an incomplete 91707, binding to the Nickel ions present in the column and being eluted 
with high concentration of Imidazole. 
Figure 20. SDS-PAGE analysis of the purification of 91707-His by IMAC from 250ml culture. A – Coomassie Gel; B – 
Western Blot.  
L – PageRuler Plus Prestained Protein Ladder; Lysate – Clear Protein Lysate; FT – Flowthrough; WS1 – Wash Fractions 
1; WS2 – Wash Fractions 2; PF – Protein Fractions.  
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After inducing another 1L of bacteria culture to express 91707-His, a new purification 
was made, using the new buffers chosen: resuspension buffer, wash buffer 2 and elution buffer, 
all without Triton. The results from this purification are shown in Figure 21. By analyzing the 
Coomassie gel and the Western Blot, the induction of expression of 91707-His seems to be 
positive, since one band around 60kDa can be seen in the Induced fraction in the Coomassie gel, 
which in turn gives a strong and clear signal in the Western Blot. The clear protein lysate and 
Flowthrough present a high protein content, which results in a huge background in the Western 
Blot, being imperceptible a signal from the his-tagged the protein in these fractions. The wash 
fraction shows the elution of unspecific bound proteins but not a his-tag signal in the Western 
blot, indicating that 91707-His was not eluted during the column wash. Concerning protein 
fraction samples it is present a strong band in both lanes with the correct molecular weight. Some 
accessory bands with distinct molecular weights are also present, which resemble the protein 
pattern present in the wash fraction lane. This means that the wash volume used in this 
purification should have been increased. In the protein fraction present in the Western Blot, there 
are present two faint bands, one of them with the expected molecular weight for 91707-His. 
However, the bands in the Coomassie gel which apparently correspond to these ones are strong. 
Thus, it was expected a stronger signal in the Western Blot for these same bands.  
 
Figure 21. SDS-PAGE analysis of the purification of 91707-His by IMAC from 1L culture. A – Coomassie Gel; B – 
Western Blot.  
L – PageRuler Plus Prestained Protein Ladder; NI – Non-Induced Fraction; I – Induced Fraction; Lysate – Clear Protein 
Lysate; FT – Flowthrough; W – Wash Fractions; PF – Protein Fractions.  
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Figure 22 represents the chromatogram from this purification obtained with the 
analyzer software ChromLab™. The green line represents the protein content distributed by the 
fractions collected along the chromatography and it is detected in an absorbance peak of 280nm 
due to the aromatic ring present in some amino acids, such as histidine and tryptophan. The red 
line represents the conductivity in the fraction, which increases exactly when the wash buffer (2) 
is injected due to an increase of NaCl concentration. The conductivity level is unaffected from this 
point on since the concentration of NaCl is the same in the wash and elution buffers.    
A new Western Blot was performed with the same samples to reevaluate the 
purification in case some mistake had been made during the process. The results were exactly the 
same. Thus, the proteins fractions were desalted, meaning 91707-His was placed in a new buffer 
without Imidazole. The high amount of Imidazole present in the eluted fractions may harm the 
rabbit during the boosts. However, the removal of the Imidazole may lead to protein precipitation 
since this alkaloid stabilizes the molecule.  
The desalted fractions were then processed in a size exclusion chromatography (SEC) to 
exclude proteins with a different size of 91707-His. The chromatogram from SEC is present in 
Figure 23. The three peaks represent the fractions with higher protein content.  
Figure 22. Chromatogram of the purification of 91707-His from 1L of culture with ChromLab™ software. 
Figure 23. Chromatogram of the size exclusion chromatography of 91707-His using ChromLab™ software. 
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These three fractions corresponding to the three peaks were evaluated by SDS-PAGE 
followed by Western Blot and its result can be seen in Figure 24. In all fractions was observed 
more than one band. In fraction 5G, two bands with close molecular weight are observed. Both 
bands show an apparent correct molecular weight for 91707-His. However, this may indicate 
protein degradations along the purification. Therefore, a protein sample will be send to the Mass 
Spectrometry facilities in Uppsala University to evaluate if 91707-His is, in fact, present in the SEC 
fraction, before trying to repeat the whole procedure to obtain the protein. 
  
Figure 24. SDS-PAGE 
analysis Size Exclusion 
Fractions of 91707-his. 
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4.3 Bioinformatics Analysis & miRNA regulatory target sequences in HCPs 
In this part of the project a strategy was design and followed in order to evaluate if 
some HCPs could be regulated by microRNAs. For this purpose I searched for shared sequence 
homology across the 3’end and 3’UTR regions of the whole HCP family which could indicate the 
presence of binding sites for a regulatory element. 
150 nucleotides from the 3’end and 3’UTR from 82 HCP sequences were aligned using 
the online tool Clustal Omega. According to the sequence homology, 33 HCPs were grouped as 
shown in Table 3. In Appendix 8.2 can be found an example of the alignment of the sequence in 
Group 1. 
 Table 4. HCPs grouping according to the alignment of the 3’end and 3’UTR sequences. 
 
 
 
 
 
 
 
 
 
 
After grouping the selected HCPs, the seed regions of 50 putative miRNA published in 
Zhang et al., (2009) and mir6 and mir10, two confirmed miRNA in Giardia (Li et al., 2012), were 
matched with the 3’end and 3’UTR sequences present in the five groups. Table 4 shows in which 
HCP sequence the seed region of a determined miRNA is present. 
 
 
HCP 
SUBGROUP 
GENES 
1 
GL50803_113531            GL50803_114626       
GL50803_137727            GL50803_113836      
GL50803_114161  
2 
GL50803_113987            GL50803_27717         
GL50803_103943            GL50803_112126       
GL50803_87706              GL50803_114891 
3 
GL50803_115158            GL50803_10659          
GL50803_101589            GL50803_113512       
GL50803_14783              GL50803_114470     
GL50803_32701              GL50803_112673        
GL50803_112135        
4 
GL50803_16936             GL50803_14791         
GL50803_17380             GL50803_112584        
GL50803_113801           GL50803_114852 
       GL50803_114888           GL50803_137672 
5 
GL50803_7715                GL50803_15008        
GL50803_91707              GL50803_112604         
GL50803_102180 
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                      Table 5. Identification of putative miRNA regulation sites in HCPs grouped sequences 
Groups Protein Targeting miRNA 
Group 
1 
GL50803_113531 Gl-mir-23,  
GL50803_114626 Gl-mir-23, 
GL50803_137727 - 
GL50803_113836 Gl-mir-34, Gl-mir-46 
GL50803_114161 Gl-mir-34, 
Group 
2 
GL50803_113987 Gl-mir-41 
GL50803_27717 Gl-mir-26, Gl-mir-41 
GL50803_103943 Gl-mir-26, Gl-mir-41 
GL50803_112126 Gl-mir-3, Gl-mir-5, Gl-mir-20, Gl-mir-41 
GL50803_87706 Gl-mir-5, Gl-mir-34, Gl-mir-41 
GL50803_114891 Gl-mir-5, Gl-mir-34, Gl-mir-41 
Group 
3 
GL50803_115158 Gl-mir-35,  
GL50803_10659 Gl-mir-5, Gl-mir-18,Gl-mir-45, mir10  
GL50803_101589 Gl-mir-5, Gl-mir-20,  Gl-mir-32 
GL50803_113512 Gl-mir-30, 
GL50803_14783 
Gl-mir-5, Gl-mir-30, Gl-mir-49, Gl-mir-50, 
mir10*   
GL50803_114470 Gl-mir-5, Gl-mir-30 
GL50803_32701 Gl-mir-11, Gl-mir-18 
GL50803_112673 Gl-mir-2, Gl-mir-7, Gl-mir-13, Gl-mir-14 
GL50803_112135 Gl-mir-2, Gl-mir-7, Gl-mir-15 
Group 
4 
GL50803_16936 Gl-mir-2, Gl-mir-39, Gl-mir-49,  
GL50803_14791 Gl-mir-23, 
GL50803_17380 Gl-mir-7, Gl-mir-10 
GL50803_112584 Gl-mir-43 
GL50803_113801 Gl-mir-3, 
GL50803_114852 - 
GL50803_114888 - 
GL50803_137672 - 
Group 
5 
GL50803_7715 Gl-mir-5 
GL50803_15008 Gl-mir-34 
GL50803_91707 Gl-mir-1, Gl-mir-5, Gl-mir-22, Gl-mir-36 
GL50803_112604 Gl-mir-16 
GL50803_102180 Gl-mir-26, Gl-mir-31 
 
After assessing that some HCPs sequences contain putative regulation target sites for 
miRNA, it was decided to test if some of these miRNAs, particularly the most frequent ones and 
tested in Giardia, could be detected. To do so, Stem-Loop RT-qPCR (SLRT-qPCR) was performed 
using specific primers to these miRNAs. In the first SLRT-qPCR assay was used total RNA from 
Giardia intestinalis to test the primers. Primers designed to target and amplify miRNA are 
extremely short, which can lead to an annealing in unspecific regions. The primers designed for 
SLRT-qPCR can be found in Annex 8.1. In the end, the samples were evaluated in 1% agarose gel, 
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shown in Figure 25. NTC (non-template control) sample for mir2 was selected because it showed 
detection in the qPCR curve analysis. Since this is a non-template control, it should not have given 
an amplification product. 
  
 
 
 
 
Samples from mir5, mir22, mir41 and mir10 showed several PCR products with a base-
pair number higher than 100bp. The miRNAs that are being targeted have an average length of 
25nt plus the bases added by the Stem-loop primer, whereby smaller products should have been 
detected. Due to the short length of the primers, it might have happened non-specific annealing, 
which lead to the amplification of the snoRNA from where these miRNAs are derived, rather than 
the respective miRNAs or other completely unrelated transcripts. Some of mir2 PCR products 
have a length below 100bp, which may indicate a correct amplification of the target miRNA with 
this set of primers. However, since a PCR product was present in the NTC for this miRNA, it was 
presumed that a contamination might have happened. Finally, mir6 samples showed PCR 
products of the expected sizes. Additionally, the control for this miRNA, mir6C, did not show any 
amplification, indicating that this set of primers has worked. Even though mir6 is not present in 
Table 5, this miRNA was found in some HCP sequences when longer 3’UTR were considered. Thus, 
a new SLRT-qPCR was performed with these two sets of primers. This time, the template used in 
the reaction was total RNA extracted from trophozoites during interaction with intestinal 
epithelial cells (IEC) in different time points. Total RNA from two biological replicates were used. 
The results obtained from the qPCR reaction were evaluated according to the following 
formulas:  
(1)                                        
(2)                      
Figure 25. Analysis of samples from SLRT-qPCR in 1% agarose gel.   
L – GeneRuler 100 bp DNA Ladder (thermo ScientificTM). 
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Formula (2) for comparative analysis was adjusted since      could not be calculated, 
due to the absence of a reference gene, a gene which expression is constant during the whole 
experiment which represents the background of the method. Based on this a relative 
quantification of the change in expression levels is obtained as compared to the use of a standard 
curve method (Absolute Quantification) for which we did not have enough material.  
When analyzing the graphs Figure 26, both in replicates A and B there is a decrease in 
the expression level of mir6 up to 3h of interaction when compared to samples at time 0 (A0 and 
B0). These samples consist in total RNA collected from throphozoites before the interaction with 
IEC.  In replicate A, when looking at the sample from 4.5h of interaction, the expression of mir6 
seems to increase to a level very close to the control one. However, in replicate B there is also an 
increase of mir6 expression when comparing to earlier time points from interaction samples, but 
it does not reach the level verified in the control sample.  
During parasite-host interactions a set of HCPs showed very high fold up-regulation 
(unpublished data), including 7715 and 91707. If mir6 is, in fact, regulating the expression of some 
HCPs, it makes sense that the level of this miRNA decreases throughout interactions. During 
interactions the trophozoites are obviously under different conditions than the ones they face 
when cultures in vitro, for instance exposure to IEC secretion products and higher O2 
concentration. The levels of O2 also vary a lot in the intestine, whereby HCPs may play a role to 
protect the parasite from the oxygen stress.  
A B 
Figure 26. Expression level of mir6 miRNA in the biological replicates A and B. 
A0/B0 – Control sample; A1.5/B1.5 – Interaction during 1.5h; A3/B3 – Interaction during 3; A4.5/B4.5 – 
Interaction during 4.5h. 
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5. Concluding Remarks 
 
The High Cysteine Protein family is a novel protein group in Giardia intestinalis which is 
very poorly studied. Due to the similarities between HCP and VSP protein family there were 
three main objectives in this project. The first one was to confirm that localization changes in 
these HCPs were really occurring in vitro. If so, and to avoid extra factors associated to episomal 
protein expression, the second objective is focused on the expression and purification of 
recombinant HCPs for the production of specific antibodies to evaluate the cellular localization 
of 91707. Finally, verify the presence of one or more regulatory elements of transcription by 
miRNAs in some HCPs sequences to evaluate if this protein group could be regulated in the 
same way as VSPs are. 
Along the different parts of the project there were some limitations which delayed its 
progression. One of the limitations of cellular localization of 91707-HA by immunofluorescence 
assay was the episomal protein expression, which may lead to a mislocalization of the tagged 
protein. Besides this, the use of antibodies with a confirmed target and localization in Giardia 
should have been used, since protein co-localization usually results in a more accurate cellular 
localization. One limitation of the expression of 91707-His in Escherichia coli was the production 
of the recombinant protein on its insoluble form. This is a very common problem associated to 
the expression of recombinant proteins in this host. Additionally, the purification of 91707-His 
by IMAC resulted in a low yield of pure recovered protein, given that there was a very dubious 
detection of the recombinant protein in Western Blots. Regarding the determination of target 
miRNA regulation sequences, many of the miRNAs tested by SLRT-qPCR were not detected, 
whereby only mir6 was tested and indicated a potential regulation of the HCP family. 
This research project was very broad and complete regarding both concepts and 
techniques and it lead to new ideas for the characterization of this protein family. It is important 
to remember that this study is part of a bigger project and there are several other studies to 
perform in order to follow up the notions revealed here.  
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6. Future Studies 
 
Since High Cysteine Proteins in Giardia intestinalis are a poorly studied protein family, 
there are several studies that can be made in order to achieve more insights about this 
particular protein group.  Starting from the results obtained in this project, the production and 
usage of the specific antibody against 91707 is the most immediate future step. The application 
of this antibody would be extremely important to evaluate the protein synthesis and transport 
in the cell in non-transfected cell lines. Additionally, a putative secretion of 91707 could be 
detected both in normal growth conditions and during interaction with host cells. Besides this, 
the trophozoites could be subjected to stress conditions, such as treatment with H2O2, to 
produce cellular redox stress and, thus, evaluate changes at the protein level both by Western 
Blots and Immunofluorescence assays. Further on, the purified recombinant protein could also 
be used to assess its binding in vitro to intestinal epithelial cells, if this is what justifies the 
secretion of these proteins during parasite-host interactions.  
Regarding the putative miRNA regulation of HCPs, more work is needed to evaluate if 
these groups of proteins or, at least, some members, are actually targets of these miRNAs in the 
same way VSPs are. The overexpression of particular miRNAs in vitro such as mir6 and 
observation of the transcript levels of HCPs is one step to follow up this regulation; however, it 
will still not completely proven the regulation at this level. Further on, regulation at the 
chromatin level should be explored as well. 
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8. Appendix 
8.1 Primers designed and tested along the project 
 
 
 
Table 6. Designed primers for 91707 and 7715 PCR amplification and analyzed features. FW – Forward;  
RV – Reverse. 
       
 
 
 
 
             
  
Gene Primer 
Number of 
nucleotides 
GC 
Content 
Melting 
Temp. 
7715 
RV 
5'- GATAATCATTGTCGTAACCGGCACCC -3' 
26 50.0 % 59.6 °C 
FW 
5’- ATGCCCCTGCGCAACTCGCCCTAT -3’ 
24 62.5 % 67.2 °C 
91707 
RV 
5’- GAGAATGTACCCCTCCATG -3’ 
19 52.6 % 52.1°C 
FW 
5’- ATGGATAGTTCGACTCCGTATGTAAAC -3’ 
27 40.7 % 56.1°C 
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                Table 7. Designed primers for the miRNAs tested with the HCP sequences. 
 
 
 
 
 
 
 
 
 
 
  
Transcript Primer 
Number of 
nucleotides 
mir2 
SLRT 
5´-GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCAC-GCACTG-3’ 
40 
FW 
5’-GAGTCGGGCAGGA-3’ 
13 
mir5 
SLRT 
5´-GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCAC-CGGAAAG-3’ 
41 
FW 
5’-GAGTCGGAGCAGA-3’ 
13 
mir6 
SLRT 
5´-GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCAC-CAGAAT-3’ 
 
40 
FW 
5’-GAGTCGGGACGCG-3’ 
13 
mir6-C 
SLRT 
5´-GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCAC-TCGTCA-3’ 40 
FW 
5’-GAGTAGGTGATGA-3’ 13 
mir10 
SLRT 
5´-GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCAC-GGTCAG-3’ 
40 
FW 
5’-GAGTCGGTGAGGA-3’ 
13 
mir22 
SLRT 
5´-GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCAC-TGTACA-3’ 
40 
FW 
5’-GAGTCGGTGTAAC-3’ 13 
mir41 
SLRT 
5´-GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCAC-AGAGGC-3’ 
40 
FW 
5’-GAGTCAGCCCGTT-3’ 13 
GlsR15 
SLRT 
5´-GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCAC-GGAGTC-3’ 
40 
FW 
5’-GAGTCGGGATTCA-3’ 13 
Universal 
Primer 
RV 
5´-GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCAC-3’ 34 
SLRT 
5´-GTGCAGGGTCCGAGGT-3’ 16 
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8.2 Example of HCP Grouping based on sequence homology using 
ClustalOmega software  
GL50803_113531      -------CATCTCATGCCGGTTCTAGTG--TCCAGCT---CTAGTTCGCCGCCATCCATG 
GL50803_114626      -------CATCTCATGCCGGTTCTAGTG--TCCAACT---CTAGTTCGCCGCCATCCATG 
GL50803_137727      -------TGTCTGGTGCCAACTCCAGCA--TCCAACT---TTGATACCGTTATTGTCTGT 
GL50803_113836      -------CGTCCAACGTCAACTCCAGCA--TCCAGCT---CTAGCCCGCTGCCCGCAAGG 
GL50803_114161      -------TGTCTGGTGCCAACTCCAGCA--TCCAGCT---CTAGCCCGCTGCCCGCAAGG 
 
GL50803_113531      -------------------------------G-CGCCCCTACTGAGCCG-GT-------- 
GL50803_114626      -------------------------------G-CGCCCCTACTGAGCCG-GT-------- 
GL50803_137727      -------------------------------G-TGCCCCTGCTGAGTCA-GC-------- 
GL50803_113836      -------------------------------G-TGCCCCTGCTGAGCCA-GG-------- 
GL50803_114161      -------------------------------G-TGCCCCTGCTGAGTCA-GC-------- 
 
GL50803_113531      CAAGATA------TTGCAGCATGCACG-AGTCGGTCCTCCAA-AACT----GTAAATCTG 
GL50803_114626      CAAGATA------TTACAGCATGCACG-AGTTGGCCCTCCAA-AACT----GTAAATCTG 
GL50803_137727      GCGGAGC------ATTGGTTTTGGTGA-TGC-AGTGGCGTAT-AAAT----TTA--TGGG 
GL50803_113836      TGTCGGT------ATTGGTAAGTCGA--------CGGCGCGG-ATCT----GCA--TACG 
GL50803_114161      TGTCGGT------ATTGGTAAGTCGA--------CGGCGCGG-ATCT----GCA--TACG 
 
GL50803_113531      GG-TATAAGACTCATTCGA-CTCGAGTAGAGGA-ATCA---------T------------ 
GL50803_114626      GG-TATAAGACTCACTCAG-CTCGAGTAGAGGA-ATCA---------T------------ 
GL50803_137727      TT-CGGAATTGTAAATTG------AGGGTATGG-AAACC---ACCTATCA---------- 
GL50803_113836      AA-TGTAAACATGATTTAC-TTCGAGGTTAGTT-TGTCA---ACTGCTGTC--------- 
GL50803_114161      AA-TGTAAATTGAAACGTA-AGAGACGGGCCGG-TTAGT---GCTTAGAAC--------- 
 
GL50803_113531      ------------------------- 
GL50803_114626      ------------------------- 
GL50803_137727      ------------------------- 
GL50803_113836      ------------------------- 
GL50803_114161      ------------------------- 
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8.3  Putative miRNAs in Giardia intestinalis (Zhang et al., 2009) 
 
Table 8. Putative miRNAs (Zhang et al., 2009) and mir6 and mir10 (Li et al., 2012) from Giardia intestinalis 
matched with HCP sequences.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                    mir6* and mir10* are tested and confirmed miRNAs (Li et al., 2012).
miRNA Sequence 5’-3’ 
Seed Region 
(2-7 nt) 
DNA seq. 
DNA seq. Reverse 
Complement 
Gl-mir-1 cucaucuauacacagugucgc ucaucu tcatct agatga 
Gl-mir-2 gcaggaguugcagcgcagugc caggag caggag ctcctg 
Gl-mir-3 cucuaccuccugacugcauug ucuacc tctacc ggtaga 
Gl-mir-4 aucgcacaccauagccuugug ucgcac tcgcac gtgcga 
Gl-mir-5 agcagagaaagugucuuuccg gcagag gcagag ctctgc 
Gl-mir-6 aggucggacucgcgcgccucc ggucgg ggtcgg ccgacc 
Gl-mir-7 ggaccaggccgucgucgaagu gaccag gaccag ctggtc 
Gl-mir-8 uagcacggcgaucugugucug agcacg agcacg cgtgct 
Gl-mir-9 aggacguagaugaugacaucu ggacgu ggacgt acgtcc 
Gl-mir-10 gaggucuucuuccaaggcaau aggucu aggtct agacct 
Gl-mir-11 cuauaagaagagauaucuugu uauaag tataag cttata 
Gl-mir-12 uagcuuaugguaguugcaccu agcuua agctta taagct 
Gl-mir-13 cgugcgcaccccccuugguau gugcgc gtgcgc gcgcac 
Gl-mir-14 gacgaagaucgcgccccacga acgaag acgaag cttcgt 
Gl-mir-15 cauccauguagacaucuugcg auccau atccat atggat 
Gl-mir-16 ugggagcgugugcacaggcag gggagc gggagc gctccc 
Gl-mir-17 agugcgaggaccaacgcgguu gugcga gtgcga tcgcac 
Gl-mir-18 ccccucuguggacucgugagu cccucu ccctct agaggg 
Gl-mir-19 guccgauuaccaacccuuuga uccgau tccgat atcgga 
Gl-mir-20 ugagcagaucucagagguaua gagcag gagcag ctgctc 
Gl-mir-21 ugaguacugguuuugcaccuu gaguac gagtac gtactc 
Gl-mir-22 uguaacagucauacauguaca guaaca gtaaca tgttac 
Gl-mir-23 cgugcauggaauaguguguau gugcau gtgcat atgcac 
Gl-mir-24 ugucuuuugaagagcuuugug gucuuu gtcttt aaagac 
Gl-mir-25 agaucuggaucgccuucagcu gaucug gatctg cagatc 
Gl-mir-26 cgugcgggcccgggggcaggg gugcgg gtgcgg ccgcac 
Gl-mir-27 uuggcuacugcagucagcucu uggcua tggcta tagcca 
Gl-mir-28 ugagaucauagagccgcuuug gagauc gagatc gatctc 
Gl-mir-29 cccuucaaaucccugauuaug ccuuca ccttca tgaagg 
Gl-mir-30 cagcguguguguccugccgag agcgug agcgtg cacgct 
Gl-mir-31 cgaggagacguuggagaaugu gaggag gaggag ctcctc 
Gl-mir-32 guagcaaagauccuucuugcu uagcaa tagcaa ttgcta 
Gl-mir-33 aucgaaagcacucuggaggcu ucgaaa tcgaaa tttcga 
Gl-mir-34 cgccgucacggagguccgccg gccguc gccgtc gacggc 
Gl-mir-35 aguguaucuaaaaccuggcac guguau gtgtat atacac 
Gl-mir-36 ugccagguuuuagauacacua gccagg gccagg cctggc 
Gl-mir-37 auccauguuguagcgcugguu uccaug tccatg catgga 
Gl-mir-38 ucccugaagguacuuggcuaa cccuga ccctga tcaggg 
Gl-mir-39 cccagagugucgucucucagc ccagag ccagag ctctgg 
Gl-mir-40 uccgguagguauuuuauaaau ccggua ccggta taccgg 
Gl-mir-41 cccguuucuuggggugccucu ccguuu ccgttt aaacgg 
Gl-mir-42 ccagucauacauguacacagu caguca cagtca tgactg 
Gl-mir-43 gaugggugguaaugaggccug augggu atgggt acccat 
Gl-mir-44 aagcugcuuguuugugaaguc agcugc agctgc gcagct 
Gl-mir-45 uggauucaggccgcgcguguu ggauuc ggattc gaatcc 
Gl-mir-46 gagcaguagcugccuuugaua agcagu agcagt actgct 
Gl-mir-47 uucgaaauaggagccaagagu ucgaaa tcgaaa tttcga 
Gl-mir-48 ggcguccaugcaccugacgcu gcgucc gcgtcc ggacgc 
Gl-mir-49 aggugcauggacgccgggcgc ggugca ggtgca tgcacc 
Gl-mir-50 cacgagagugcgcgaccgggg acgaga acgaga tctcgt 
mir6* gacgcgtgacgaagtttgtcgtattctg acgcgt acgcgt acgcgt 
mir10* tgaggaagaaaccgcctttcgtctgacc gaggaa gaggaa ttcctc 
                    
                                                         
73 
 
8.4  Composition of Reagents and Solutions used in the project  
Reagent/Solution Composition Use 
Tris-acetate buffer (TAE) 40mM Tris, 20mM Acetic Acid, 1mM EDTA. Agarose Gels 
TFBI 30mM KC2H3O2, 100mM RbCl, 10mM CaCl2*2H2O, 50mM MnCl2*4H2O, 15% glycerol – pH 5.8. Competent Cells 
TFBII 10mM MOPS, 10mM RbCl, 75mM CaCl2*2H2O, 15% glycerol – pH 6.6. Competent Cells 
TYDK 
30 mg/ml Peptone, 55.6mM Glucose, 34.2mM NaCl, 1.14mM L‐ascorbic acid, 5.74mM K2HPO4,  
4.41mM  KH2PO4 , 11.4mM  L‐cysteine  hydrochloride  monohydrate, 0.038mM ferric ammonium 
citrate – pH 6.8 
Giardia intestinalis 
trophozoites media 
HBS-glucose buffer 130mM NaCl, 5mM KCl, 10mM glucose, 1mM MgCl2  – pH 7.4  IF Assay 
Running Buffer 25 mM Tris, 192 mM glycine, 0.1% SDS SDS_PAGE 
Transfer Buffer 25 mM Tris, 192 mM glycine, 20% methanol Westren Blot 
Resuspension/Binding 
Buffer A 
HEPES 100mM pH 8; DDT 2mM; NaCl 200mM; Triton 1%; Glycerol 20%; 10mM Imidazol; Proteinase 
Inhibitors. 
Protein Purification by 
IMAC 
Wash Buffer A DDT 2mM; NaCl 200mM; HEPES 100mM pH 8; Triton 1%; Glycerol 20%. 
Elution Buffer A DDT 2mM; NaCl 200mM; HEPES 100mMpH 8; Triton 1%; Glycerol 20%, 500mM Imidazole. 
Resuspension/Binding 
Buffer B 
HEPES 100mM pH8; NaCl 200mM; DTT 1mM; Glycerol 10%; Imidazole 5mM; DNAseI-RNAseA 
20ug/ml each. 
Wash Buffer 1 B 
HEPES pH8 100mM; NaCl 300mM; DTT 1mM; Glycerol 10%; Imidazole 5mM. 
Wash Buffer 2 B 
HEPES pH8 100mM; NaCl 500mM; DTT 1mM; Glycerol 10%; Imidazole 10mM. 
Elution Buffer B 
HEPES pH8 100mM; NaCl 500mM; DTT 1mM; Glycerol 10%; Imidazole 500mM. 
Desalting Buffer 
HEPES pH8 100mM; NaCl 500mM; DTT 1mM; Glycerol 10%. 
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